ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
APCDL_HUMAN	APC down-regulated 1 like(APCDD1L)	Homo sapiens					GO:0016021~integral component of membrane,						SM01352:SM01352,	Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Protein APCDD1-like,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,transmembrane region,
AT1B1_HUMAN	ATPase Na+/K+ transporting subunit beta 1(ATP1B1)	Homo sapiens				GO:0001666~response to hypoxia,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0006883~cellular sodium ion homeostasis,GO:0007155~cell adhesion,GO:0010107~potassium ion import,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0010468~regulation of gene expression,GO:0010882~regulation of cardiac muscle contraction by calcium ion signaling,GO:0030007~cellular potassium ion homeostasis,GO:0032781~positive regulation of ATPase activity,GO:0034220~ion transmembrane transport,GO:0036376~sodium ion export from cell,GO:0044861~protein transport into plasma membrane raft,GO:0046034~ATP metabolic process,GO:0050821~protein stabilization,GO:0050900~leukocyte migration,GO:0055119~relaxation of cardiac muscle,GO:0060048~cardiac muscle contraction,GO:0072659~protein localization to plasma membrane,GO:0086009~membrane repolarization,GO:0086013~membrane repolarization during cardiac muscle cell action potential,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:0090662~ATP hydrolysis coupled transmembrane transport,GO:1901018~positive regulation of potassium ion transmembrane transporter activity,GO:1903278~positive regulation of sodium ion export from cell,GO:1903281~positive regulation of calcium:sodium antiporter activity,GO:1903288~positive regulation of potassium ion import,GO:1903779~regulation of cardiac conduction,GO:1990573~potassium ion import across plasma membrane,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0005901~caveola,GO:0014704~intercalated disc,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0042383~sarcolemma,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0001671~ATPase activator activity,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008144~drug binding,GO:0016887~ATPase activity,GO:0023026~MHC class II protein complex binding,GO:0030955~potassium ion binding,GO:0031402~sodium ion binding,GO:0051117~ATPase binding,	IPR000402:Sodium/potassium-transporting ATPase subunit beta,IPR015565:Sodium/potassium-transporting ATPase subunit beta, chordates,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,	145500~Blood pressure regulation QTL,			Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Potassium,Potassium transport,Proteomics identification,Reference proteome,Signal-anchor,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/potassium-transporting ATPase subunit beta-1,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
C9JLA2_HUMAN	BTG anti-proliferation factor 3(BTG3)	Homo sapiens				GO:0008285~negative regulation of cell proliferation,GO:0045930~negative regulation of mitotic cell cycle,	GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR002087:Anti-proliferative protein,	hsa03018:RNA degradation,			SM00099:btg1,	Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,	chain:Protein BTG3,compositionally biased region:Poly-Ser,sequence conflict,splice variant,
CCL20_HUMAN	C-C motif chemokine ligand 20(CCL20)	Homo sapiens	109.Chemokine_families,			GO:0002548~monocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0030593~neutrophil chemotaxis,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0042060~wound healing,GO:0042742~defense response to bacterium,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050726~positive regulation of interleukin-1 alpha biosynthetic process,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071222~cellular response to lipopolysaccharide,GO:0071223~cellular response to lipoteichoic acid,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0072678~T cell migration,GO:0072679~thymocyte migration,GO:2000406~positive regulation of T cell migration,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,	GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0031731~CCR6 chemokine receptor binding,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04668:TNF signaling pathway,hsa05323:Rheumatoid arthritis,			SM00199:SCY,	3D-structure,Alternative splicing,Antibiotic,Antimicrobial,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Polymorphism,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 20,chain:CCL20(1-64),chain:CCL20(1-67),chain:CCL20(2-70),disulfide bond,helix,sequence variant,signal peptide,splice variant,strand,turn,
GROA_HUMAN	C-X-C motif chemokine ligand 1(CXCL1)	Homo sapiens				GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007399~nervous system development,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0030036~actin cytoskeleton organization,GO:0032496~response to lipopolysaccharide,GO:0035556~intracellular signal transduction,GO:0043085~positive regulation of catalytic activity,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0090023~positive regulation of neutrophil chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,	GO:0005102~receptor binding,GO:0008009~chemokine activity,GO:0008047~enzyme activator activity,GO:0008083~growth factor activity,GO:0045236~CXCR chemokine receptor binding,	IPR001089:CXC chemokine,IPR001811:Chemokine interleukin-8-like domain,IPR018048:CXC chemokine, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04668:TNF signaling pathway,hsa05132:Salmonella infection,hsa05134:Legionellosis,			SM00199:SCY,	3D-structure,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Growth factor,Inflammatory response,Reference proteome,Secreted,Signal,	chain:GRO-alpha(4-73),chain:GRO-alpha(5-73),chain:GRO-alpha(6-73),chain:Growth-regulated alpha protein,disulfide bond,helix,signal peptide,strand,turn,
CXCL5_HUMAN	C-X-C motif chemokine ligand 5(CXCL5)	Homo sapiens				GO:0002446~neutrophil mediated immunity,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0008284~positive regulation of cell proliferation,GO:0032496~response to lipopolysaccharide,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0008009~chemokine activity,GO:0045236~CXCR chemokine receptor binding,	IPR001089:CXC chemokine,IPR001811:Chemokine interleukin-8-like domain,IPR018048:CXC chemokine, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa05133:Pertussis,hsa05323:Rheumatoid arthritis,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Reference proteome,Secreted,Signal,	chain:C-X-C motif chemokine 5,chain:ENA-78(8-78),chain:ENA-78(9-78),disulfide bond,signal peptide,site:Cleavage; by cathepsin G,
IL8_HUMAN	C-X-C motif chemokine ligand 8(CXCL8)	Homo sapiens	109.Chemokine_families,18.Cytokine_astocytes,22.Cytokine-chemokine_CNS,58.(CD40L)_immnosurveillance,7.IL17_hematopoesis,	h_cytokinePathway:Cytokine Network,h_freePathway:Free Radical Induced Apoptosis,h_granulocytesPathway:Adhesion and Diapedesis of Granulocytes,h_il17Pathway:IL 17 Signaling Pathway,h_inflamPathway:Cytokines and Inflammatory Response,h_LairPathway:Cells and Molecules involved in local acute inflammatory response,h_lymPathway:Adhesion and Diapedesis of Lymphocytes,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_pepiPathway:Proepithelin Conversion to Epithelin and Wound Repair Control,h_stemPathway:Regulation of hematopoiesis by cytokines,		GO:0001525~angiogenesis,GO:0002237~response to molecule of bacterial origin,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007050~cell cycle arrest,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0019722~calcium-mediated signaling,GO:0030155~regulation of cell adhesion,GO:0030593~neutrophil chemotaxis,GO:0031623~receptor internalization,GO:0034976~response to endoplasmic reticulum stress,GO:0035556~intracellular signal transduction,GO:0036499~PERK-mediated unfolded protein response,GO:0042119~neutrophil activation,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045091~regulation of single stranded viral RNA replication via double stranded DNA intermediate,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0045766~positive regulation of angiogenesis,GO:0048566~embryonic digestive tract development,GO:0050930~induction of positive chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0071222~cellular response to lipopolysaccharide,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0090023~positive regulation of neutrophil chemotaxis,GO:2000535~regulation of entry of bacterium into host cell,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,	GO:0005153~interleukin-8 receptor binding,GO:0005515~protein binding,GO:0008009~chemokine activity,	IPR001089:CXC chemokine,IPR001811:Chemokine interleukin-8-like domain,IPR018048:CXC chemokine, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05131:Shigellosis,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05134:Legionellosis,hsa05142:Chagas disease (American trypanosomiasis),hsa05144:Malaria,hsa05146:Amoebiasis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05219:Bladder cancer,hsa05323:Rheumatoid arthritis,			SM00199:SCY,	3D-structure,Chemotaxis,Citrullination,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Proteomics identification,Reference proteome,Secreted,Signal,	chain:IL-8(5-77),chain:IL-8(6-77),chain:IL-8(7-77),chain:IL-8(8-77),chain:IL-8(9-77),chain:Interleukin-8,chain:MDNCF-a,disulfide bond,helix,sequence conflict,signal peptide,site:Cleavage; by MMP9,site:Cleavage; by thrombin,splice variant,strand,
CEBPB_HUMAN	CCAAT/enhancer binding protein beta(CEBPB)	Homo sapiens		h_il6Pathway:IL 6 signaling pathway,		GO:0001541~ovarian follicle development,GO:0001892~embryonic placenta development,GO:0002432~granuloma formation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006953~acute-phase response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007613~memory,GO:0030182~neuron differentiation,GO:0032753~positive regulation of interleukin-4 production,GO:0033598~mammary gland epithelial cell proliferation,GO:0034976~response to endoplasmic reticulum stress,GO:0035711~T-helper 1 cell activation,GO:0042130~negative regulation of T cell proliferation,GO:0042742~defense response to bacterium,GO:0043524~negative regulation of neuron apoptotic process,GO:0045408~regulation of interleukin-6 biosynthetic process,GO:0045600~positive regulation of fat cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050873~brown fat cell differentiation,GO:0060644~mammary gland epithelial cell differentiation,GO:0060850~regulation of transcription involved in cell fate commitment,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0071222~cellular response to lipopolysaccharide,GO:0071230~cellular response to amino acid stimulus,GO:0071347~cellular response to interleukin-1,GO:0071407~cellular response to organic cyclic compound,GO:0072574~hepatocyte proliferation,GO:0097421~liver regeneration,GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,	GO:0000779~condensed chromosome, centromeric region,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0036488~CHOP-C/EBP complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019900~kinase binding,GO:0035035~histone acetyltransferase binding,GO:0035259~glucocorticoid receptor binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,GO:0044389~ubiquitin-like protein ligase binding,GO:0046982~protein heterodimerization activity,	IPR004827:Basic-leucine zipper domain,IPR016468:CCAAT/enhancer-binding,	hsa04668:TNF signaling pathway,hsa05152:Tuberculosis,hsa05202:Transcriptional misregulation in cancer,		PIRSF005879:CCAAT/enhancer-binding protein,	SM00338:BRLZ,	3D-structure,Acetylation,Activator,Alternative initiation,Coiled coil,Complete proteome,Cytoplasm,Differentiation,DNA-binding,Glycoprotein,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:CCAAT/enhancer-binding protein beta,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Basic motif,domain:Leucine-zipper,helix,modified residue,region of interest:Required for Lys-174 sumoylation,sequence conflict,sequence variant,turn,
CD82_HUMAN	CD82 molecule(CD82)	Homo sapiens	73.Integrins_and_other_cell-surface_receptors,			GO:0007166~cell surface receptor signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,	hsa04115:p53 signaling pathway,	176807~Prostate cancer, susceptibility to,	PIRSF002419:tetraspanin,		Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:CD82 antigen,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CDCP1_HUMAN	CUB domain containing protein 1(CDCP1)	Homo sapiens					GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR000859:CUB domain,					Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:CUB domain-containing protein 1,disulfide bond,domain:CUB,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,sequence conflict,sequence variant,signal peptide,site:Cleavage; by ST14/MT-SP1,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
EDEM1_HUMAN	ER degradation enhancing alpha-mannosidase like protein 1(EDEM1)	Homo sapiens		h_eradPathway:ERï¿½associated degradation (ERAD) Pathway,		GO:0006491~N-glycan processing,GO:0008152~metabolic process,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0036498~IRE1-mediated unfolded protein response,GO:0036510~trimming of terminal mannose on C branch,GO:0097466~glycoprotein ERAD pathway,GO:1904154~positive regulation of retrograde protein transport, ER to cytosol,GO:1904380~endoplasmic reticulum mannose trimming,GO:1904382~mannose trimming involved in glycoprotein ERAD pathway,	GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0044322~endoplasmic reticulum quality control compartment,	GO:0001948~glycoprotein binding,GO:0004559~alpha-mannosidase activity,GO:0004571~mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0051787~misfolded protein binding,	IPR001382:Glycoside hydrolase, family 47,	hsa04141:Protein processing in endoplasmic reticulum,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosidase,Hydrolase,Membrane,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Unfolded protein response,	chain:ER degradation-enhancing alpha- mannosidase-like 1,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
FBX22_HUMAN	F-box protein 22(FBXO22)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006464~cellular protein modification process,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006913~nucleocytoplasmic transport,GO:0009267~cellular response to starvation,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0048742~regulation of skeletal muscle fiber development,GO:2000060~positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0030018~Z disc,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,IPR019494:FIST C domain,				SM01204:SM01204,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 22,domain:F-box,modified residue,sequence conflict,splice variant,
RASH_HUMAN	HRas proto-oncogene, GTPase(HRAS)	Homo sapiens	65.Integrin_affinity_modulation,	h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bArrestin-srcPathway:Roles of ï¿½-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_bcrPathway:BCR Signaling Pathway,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_cardiacEGFPathway:Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_cdk5Pathway:Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway,h_cdmacPathway:Cadmium induces DNA synthesis and proliferation in macrophages,h_crebPathway:Transcription factor CREB and its extracellular signals,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_egfPathway:EGF Signaling Pathway,h_epoPathway:EPO Signaling Pathway,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_etsPathway:METS affect on Macrophage Differentiation,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_ghPathway:Growth Hormone Signaling Pathway,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_hbxPathway:Calcium Signaling by HBx of Hepatitis B virus,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il3Pathway:IL 3 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,h_integrinPathway:Integrin Signaling Pathway,h_keratinocytePathway:Keratinocyte Differentiation,h_longevityPathway:The IGF-1 Receptor and Longevity,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_mapkPathway:MAPKinase Signaling Pathway,h_mCalpainPathway:mCalpain and friends in Cell motility,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_ngfPathway:Nerve growth factor pathway (NGF),h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pdgfPathway:PDGF Signaling Pathway,h_pmlPathway:Regulation of transcriptional activity by PML,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rasPathway:Ras Signaling Pathway,h_reckPathway:Inhibition of Matrix Metalloproteinases,h_sam68Pathway:Regulation of Splicing through Sam68,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_tpoPathway:TPO Signaling Pathway,h_trkaPathway:Trka Receptor Signaling Pathway,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0000165~MAPK cascade,GO:0001934~positive regulation of protein phosphorylation,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0006897~endocytosis,GO:0006935~chemotaxis,GO:0007050~cell cycle arrest,GO:0007093~mitotic cell cycle checkpoint,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007411~axon guidance,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009887~organ morphogenesis,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0030335~positive regulation of cell migration,GO:0032729~positive regulation of interferon-gamma production,GO:0034260~negative regulation of GTPase activity,GO:0035176~social behavior,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038128~ERBB2 signaling pathway,GO:0042088~T-helper 1 type immune response,GO:0042832~defense response to protozoan,GO:0043406~positive regulation of MAP kinase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043524~negative regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045740~positive regulation of DNA replication,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046330~positive regulation of JNK cascade,GO:0046579~positive regulation of Ras protein signal transduction,GO:0048013~ephrin receptor signaling pathway,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050852~T cell receptor signaling pathway,GO:0050900~leukocyte migration,GO:0051291~protein heterooligomerization,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0090303~positive regulation of wound healing,GO:0090398~cellular senescence,GO:0097193~intrinsic apoptotic signaling pathway,GO:1900029~positive regulation of ruffle assembly,GO:2000251~positive regulation of actin cytoskeleton reorganization,GO:2000630~positive regulation of miRNA metabolic process,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0008022~protein C-terminus binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04144:Endocytosis,hsa04151:PI3K-Akt signaling pathway,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04540:Gap junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05034:Alcoholism,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05211:Renal cell carcinoma,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	109800~Bladder cancer, somatic,137550~Spitz nevus or nevus spilus, somatic,162900~Nevus sebaceous or woolly hair nevus, somatic,163200~Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic,188470~Thyroid carcinoma, follicular, somatic,218040~Congenital myopathy with excess of muscle spindles,218040~Costello syndrome,			3D-structure,Acetylation,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Golgi apparatus,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Nucleus,Palmitate,Prenylation,Proto-oncogene,Reference proteome,S-nitrosylation,	chain:GTPase HRas,chain:GTPase HRas, N-terminally processed,helix,lipid moiety-binding region:S-farnesyl cysteine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,region of interest:Hypervariable region,sequence variant,short sequence motif:Effector region,strand,turn,
ICOSL_HUMAN	ICOS ligand(LOC102723996)	Homo sapiens				GO:0002250~adaptive immune response,GO:0006952~defense response,GO:0006972~hyperosmotic response,GO:0007165~signal transduction,GO:0031295~T cell costimulation,GO:0042104~positive regulation of activated T cell proliferation,GO:0042110~T cell activation,GO:0042113~B cell activation,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	Adaptive immunity,Alternative splicing,B-cell activation,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,
MYCBP_HUMAN	MYC binding protein(MYCBP)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,	IPR026060:Associate of Myc 1,					3D-structure,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Mitochondrion,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:C-Myc-binding protein,helix,sequence conflict,strand,turn,
OTUB2_HUMAN	OTU deubiquitinase, ubiquitin aldehyde binding 2(OTUB2)	Homo sapiens				GO:0016579~protein deubiquitination,GO:0035871~protein K11-linked deubiquitination,GO:0070536~protein K63-linked deubiquitination,GO:0071108~protein K48-linked deubiquitination,	GO:0005634~nucleus,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0019784~NEDD8-specific protease activity,GO:0043130~ubiquitin binding,	IPR003323:Ovarian tumour, otubain,IPR016615:Ubiquitin thioesterase Otubain,IPR019400:Peptidase C65, otubain,			PIRSF013503:ubiquitin thioesterase Otubain,		3D-structure,Alternative splicing,Complete proteome,Hydrolase,Protease,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Ubiquitin thioesterase OTUB2,domain:OTU,helix,mutagenesis site,site:Required to orient and stabilize the active site H-224,splice variant,strand,
U3KQ96_HUMAN	POU class 2 homeobox 2(POU2F2)	Homo sapiens	79.B_cell_Activation,			GO:0002335~mature B cell differentiation,GO:0002380~immunoglobulin secretion involved in immune response,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006959~humoral immune response,GO:0042795~snRNA transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0019904~protein domain specific binding,GO:0043565~sequence-specific DNA binding,	IPR000327:POU-specific,IPR000972:Octamer-binding transcription factor,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR010982:Lambda repressor-like, DNA-binding domain,IPR013847:POU domain,IPR017970:Homeobox, conserved site,				SM00352:POU,SM00389:HOX,	3D-structure,Activator,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Homeobox,Nucleus,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:POU domain, class 2, transcription factor 2,compositionally biased region:Gly-rich,DNA-binding region:Homeobox,domain:Leucine-zipper,domain:POU-specific,helix,modified residue,mutagenesis site,splice variant,turn,
RPOM_HUMAN	RNA polymerase mitochondrial(POLRMT)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006390~transcription from mitochondrial promoter,GO:0006391~transcription initiation from mitochondrial promoter,GO:0007005~mitochondrion organization,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0042645~mitochondrial nucleoid,	GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR002092:DNA-directed RNA polymerase, phage-type,IPR024075:DNA-directed RNA polymerase, helix hairpin domain,				SM01311:SM01311,	3D-structure,Complete proteome,DNA-directed RNA polymerase,Mitochondrion,Nucleotidyltransferase,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transferase,Transit peptide,	chain:DNA-directed RNA polymerase, mitochondrial,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
RHG06_HUMAN	Rho GTPase activating protein 6(ARHGAP6)	Homo sapiens		h_rhoPathway:Rho cell motility signaling pathway,		GO:0007015~actin filament organization,GO:0007165~signal transduction,GO:0007202~activation of phospholipase C activity,GO:0007266~Rho protein signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010518~positive regulation of phospholipase activity,GO:0030041~actin filament polymerization,GO:0043547~positive regulation of GTPase activity,GO:0048041~focal adhesion assembly,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051497~negative regulation of stress fiber assembly,GO:0051895~negative regulation of focal adhesion assembly,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005884~actin filament,GO:0015629~actin cytoskeleton,	GO:0005070~SH3/SH2 adaptor activity,GO:0005096~GTPase activator activity,GO:0016004~phospholipase activator activity,GO:0017124~SH3 domain binding,GO:0043274~phospholipase binding,	IPR000198:Rho GTPase-activating protein domain,IPR008936:Rho GTPase activation protein,				SM00324:RhoGAP,	Alternative splicing,Complete proteome,Cytoplasm,GTPase activation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3-binding,	chain:Rho GTPase-activating protein 6,domain:Rho-GAP,modified residue,sequence conflict,sequence variant,short sequence motif:SH3-binding,splice variant,
SDA1_HUMAN	SDA1 domain containing 1(SDAD1)	Homo sapiens				GO:0000055~ribosomal large subunit export from nucleus,GO:0015031~protein transport,GO:0030036~actin cytoskeleton organization,GO:0042273~ribosomal large subunit biogenesis,	GO:0005623~cell,GO:0005634~nucleus,GO:0005730~nucleolus,		IPR007949:SDA1 domain,IPR012977:Uncharacterised domain NUC130/133, N-terminal,IPR016024:Armadillo-type fold,IPR027312:Sda1,					Alternative splicing,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Ribosome biogenesis,Transport,	chain:Protein SDA1 homolog,modified residue,sequence conflict,sequence variant,splice variant,
SH3K1_HUMAN	SH3 domain containing kinase binding protein 1(SH3KBP1)	Homo sapiens		h_cblPathway:CBL mediated ligand-induced downregulation of EGF receptors,		GO:0006897~endocytosis,GO:0006915~apoptotic process,GO:0007010~cytoskeleton organization,GO:0007267~cell-cell signaling,GO:0008360~regulation of cell shape,GO:0016477~cell migration,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0016021~integral component of membrane,GO:0030139~endocytic vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0043005~neuron projection,GO:0045202~synapse,	GO:0005515~protein binding,GO:0016301~kinase activity,GO:0017124~SH3 domain binding,	IPR001452:Src homology-3 domain,IPR013315:Spectrin alpha chain, SH3 domain,	hsa04144:Endocytosis,			SM00326:SH3,	3D-structure,Alternative splicing,Apoptosis,Cell junction,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Endocytosis,Kinase,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,SH3-binding,Synapse,Synaptosome,Transferase,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:SH3 domain-containing kinase-binding protein 1,compositionally biased region:Pro-rich,domain:SH3 1,domain:SH3 2,domain:SH3 3,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
TIMP1_HUMAN	TIMP metallopeptidase inhibitor 1(TIMP1)	Homo sapiens		h_reckPathway:Inhibition of Matrix Metalloproteinases,		GO:0001775~cell activation,GO:0002576~platelet degranulation,GO:0007568~aging,GO:0008284~positive regulation of cell proliferation,GO:0009725~response to hormone,GO:0010951~negative regulation of endopeptidase activity,GO:0022617~extracellular matrix disassembly,GO:0034097~response to cytokine,GO:0042060~wound healing,GO:0043066~negative regulation of apoptotic process,GO:0043086~negative regulation of catalytic activity,GO:0043434~response to peptide hormone,GO:0051045~negative regulation of membrane protein ectodomain proteolysis,GO:0051216~cartilage development,GO:1901164~negative regulation of trophoblast cell migration,GO:1905049~negative regulation of metallopeptidase activity,GO:2001044~regulation of integrin-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0031093~platelet alpha granule lumen,GO:0070062~extracellular exosome,	GO:0002020~protease binding,GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0008191~metalloendopeptidase inhibitor activity,GO:0046872~metal ion binding,	IPR001134:Netrin domain,IPR001820:Proteinase inhibitor I35, tissue inhibitor of metalloproteinase,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR015611:Tissue inhibitor of metalloprotease 1,IPR027465:Proteinase inhibitor I35, tissue inhibitor of metalloproteinase, C-terminal domain,	hsa04066:HIF-1 signaling pathway,			SM00206:NTR,	3D-structure,Collagen,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor,Metal-binding,Metalloenzyme inhibitor,Metalloprotease inhibitor,Phosphoprotein,Protease inhibitor,Proteomics identification,Reference proteome,Secreted,Signal,Zinc,	chain:Metalloproteinase inhibitor 1,disulfide bond,domain:NTR,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Zinc; via amide nitrogen and carbonyl oxygen; shared with metalloproteinase partner,mutagenesis site,region of interest:Involved in metalloproteinase-binding,sequence conflict,signal peptide,strand,turn,
TNAP2_HUMAN	TNF alpha induced protein 2(TNFAIP2)	Homo sapiens				GO:0001525~angiogenesis,GO:0006887~exocytosis,GO:0030154~cell differentiation,GO:0051601~exocyst localization,	GO:0000145~exocyst,GO:0005615~extracellular space,	GO:0000149~SNARE binding,	IPR010326:Exocyst complex component Sec6,					Angiogenesis,Complete proteome,Developmental protein,Differentiation,Polymorphism,Proteomics identification,Reference proteome,	chain:Tumor necrosis factor, alpha-induced protein 2,compositionally biased region:Lys-rich (basic),compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,sequence variant,
TSG6_HUMAN	TNF alpha induced protein 6(TNFAIP6)	Homo sapiens				GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0030335~positive regulation of cell migration,GO:0030728~ovulation,GO:0050728~negative regulation of inflammatory response,	GO:0005615~extracellular space,	GO:0005515~protein binding,GO:0005540~hyaluronic acid binding,	IPR000538:Link,IPR000859:CUB domain,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00042:CUB,SM00445:LINK,	3D-structure,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Polymorphism,Reference proteome,Signal,	chain:Tumor necrosis factor-inducible gene 6 protein,disulfide bond,domain:CUB,domain:Link,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence variant,signal peptide,strand,
TR11B_HUMAN	TNF receptor superfamily member 11b(TNFRSF11B)	Homo sapiens				GO:0001501~skeletal system development,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007584~response to nutrient,GO:0030198~extracellular matrix organization,GO:0032026~response to magnesium ion,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042489~negative regulation of odontogenesis of dentin-containing tooth,GO:0042493~response to drug,GO:0042981~regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0043627~response to estrogen,GO:0045779~negative regulation of bone resorption,GO:0046685~response to arsenic-containing substance,GO:0097190~apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0004872~receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005125~cytokine activity,	IPR000488:Death domain,IPR001368:TNFR/NGFR cysteine-rich region,IPR011029:Death-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR017371:Tumour necrosis factor receptor 11B,IPR022323:Tumour necrosis factor receptor 11,	hsa04060:Cytokine-cytokine receptor interaction,hsa04380:Osteoclast differentiation,	239000~Paget disease of bone 5, juvenile-onset,	PIRSF038065:tumor necrosis factor receptor superfamily member 11B,	SM00005:DEATH,SM00208:TNFR,SM01411:SM01411,	3D-structure,Apoptosis,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,	chain:Tumor necrosis factor receptor superfamily member 11B,disulfide bond,domain:Death 1,domain:Death 2,glycosylation site:N-linked (GlcNAc...),mutagenesis site,repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,repeat:TNFR-Cys 4,sequence conflict,sequence variant,signal peptide,site:Involved in dimerization,
AF1L2_HUMAN	actin filament associated protein 1 like 2(AFAP1L2)	Homo sapiens				GO:0006954~inflammatory response,GO:0007346~regulation of mitotic cell cycle,GO:0032675~regulation of interleukin-6 production,GO:0032757~positive regulation of interleukin-8 production,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0045893~positive regulation of transcription, DNA-templated,GO:0061098~positive regulation of protein tyrosine kinase activity,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0017124~SH3 domain binding,GO:0030296~protein tyrosine kinase activator activity,GO:0035591~signaling adaptor activity,GO:0042169~SH2 domain binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Actin filament-associated protein 1-like 2,domain:PH 1,domain:PH 2,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
ACSL4_HUMAN	acyl-CoA synthetase long-chain family member 4(ACSL4)	Homo sapiens			Lipid metabolism,	GO:0001676~long-chain fatty acid metabolic process,GO:0006629~lipid metabolic process,GO:0006641~triglyceride metabolic process,GO:0007584~response to nutrient,GO:0008152~metabolic process,GO:0008610~lipid biosynthetic process,GO:0015908~fatty acid transport,GO:0030307~positive regulation of cell growth,GO:0032307~negative regulation of prostaglandin secretion,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0060136~embryonic process involved in female pregnancy,GO:0060996~dendritic spine development,GO:0070672~response to interleukin-15,	GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005778~peroxisomal membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005811~lipid particle,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043025~neuronal cell body,GO:0044233~ER-mitochondrion membrane contact site,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004467~long-chain fatty acid-CoA ligase activity,GO:0005524~ATP binding,GO:0031957~very long-chain fatty acid-CoA ligase activity,GO:0047676~arachidonate-CoA ligase activity,GO:0102391~decanoate--CoA ligase activity,	IPR000873:AMP-dependent synthetase/ligase,IPR020845:AMP-binding, conserved site,	hsa00061:Fatty acid biosynthesis,hsa00071:Fatty acid degradation,hsa01100:Metabolic pathways,hsa01212:Fatty acid metabolism,hsa03320:PPAR signaling pathway,hsa04146:Peroxisome,hsa04920:Adipocytokine signaling pathway,	300387~Mental retardation, X-linked 63,			Alport syndrome,Alternative splicing,ATP-binding,Complete proteome,Deafness,Disease mutation,Elliptocytosis,Endoplasmic reticulum,Fatty acid metabolism,Hereditary hemolytic anemia,Ligase,Lipid metabolism,Magnesium,Membrane,Mental retardation,Microsome,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Peroxisome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Long-chain-fatty-acid--CoA ligase 4,modified residue,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,transmembrane region,
AMPD3_HUMAN	adenosine monophosphate deaminase 3(AMPD3)	Homo sapiens				GO:0006196~AMP catabolic process,GO:0032264~IMP salvage,GO:0034101~erythrocyte homeostasis,GO:0043101~purine-containing compound salvage,GO:0046031~ADP metabolic process,GO:0046034~ATP metabolic process,GO:0046039~GTP metabolic process,GO:0097009~energy homeostasis,	GO:0005829~cytosol,	GO:0003876~AMP deaminase activity,GO:0046872~metal ion binding,	IPR001365:Adenosine/AMP deaminase domain,IPR006329:AMP deaminase,IPR006650:Adenosine/AMP deaminase active site,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	612874~AMP deaminase deficiency, erythrocytic,	PIRSF001251:AMP deaminase,		Alternative splicing,Coiled coil,Complete proteome,Disease mutation,Hydrolase,Metal-binding,Nucleotide metabolism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,	chain:AMP deaminase 3,modified residue,sequence variant,splice variant,
ALDR_HUMAN	aldo-keto reductase family 1 member B(AKR1B1)	Homo sapiens				GO:0001894~tissue homeostasis,GO:0005975~carbohydrate metabolic process,GO:0005996~monosaccharide metabolic process,GO:0006061~sorbitol biosynthetic process,GO:0006700~C21-steroid hormone biosynthetic process,GO:0006950~response to stress,GO:0009414~response to water deprivation,GO:0018931~naphthalene metabolic process,GO:0031098~stress-activated protein kinase signaling cascade,GO:0042415~norepinephrine metabolic process,GO:0044597~daunorubicin metabolic process,GO:0044598~doxorubicin metabolic process,GO:0046370~fructose biosynthetic process,GO:0046427~positive regulation of JAK-STAT cascade,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0055114~oxidation-reduction process,GO:0060135~maternal process involved in female pregnancy,GO:0070301~cellular response to hydrogen peroxide,GO:0072061~inner medullary collecting duct development,GO:0097066~response to thyroid hormone,GO:0097238~cellular response to methylglyoxal,GO:1901653~cellular response to peptide,	GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0032838~cell projection cytoplasm,GO:0033010~paranodal junction,GO:0042629~mast cell granule,GO:0043220~Schmidt-Lanterman incisure,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0097454~Schwann cell microvillus,	GO:0004032~alditol:NADP+ 1-oxidoreductase activity,GO:0004033~aldo-keto reductase (NADP) activity,GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0043795~glyceraldehyde oxidoreductase activity,	IPR001395:Aldo/keto reductase,IPR018170:Aldo/keto reductase, conserved site,IPR020471:Aldo/keto reductase subgroup,IPR023210:NADP-dependent oxidoreductase domain,	hsa00040:Pentose and glucuronate interconversions,hsa00051:Fructose and mannose metabolism,hsa00052:Galactose metabolism,hsa00561:Glycerolipid metabolism,hsa01100:Metabolic pathways,		PIRSF000097:aldo-keto reductase,		3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Proton donor,binding site:Substrate,chain:Aldose reductase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:NADP,sequence conflict,sequence variant,site:Lowers pKa of active site Tyr,strand,turn,
ANGL4_HUMAN	angiopoietin like 4(ANGPTL4)	Homo sapiens				GO:0001525~angiogenesis,GO:0001666~response to hypoxia,GO:0030154~cell differentiation,GO:0043066~negative regulation of apoptotic process,GO:0045766~positive regulation of angiogenesis,GO:0051005~negative regulation of lipoprotein lipase activity,GO:0051260~protein homooligomerization,GO:0070328~triglyceride homeostasis,GO:2000352~negative regulation of endothelial cell apoptotic process,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0072562~blood microparticle,	GO:0004857~enzyme inhibitor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR014715:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,IPR020837:Fibrinogen, conserved site,	hsa03320:PPAR signaling pathway,	615881~Plasma triglyceride level QTL, low,		SM00186:FBG,	Alternative splicing,Angiogenesis,Coiled coil,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Extracellular matrix,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Angiopoietin-related protein 4,disulfide bond,domain:Fibrinogen C-terminal,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
AHR_HUMAN	aryl hydrocarbon receptor(AHR)	Homo sapiens		h_acrPathway:Ahr Signal Transduction Pathway,		GO:0001568~blood vessel development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006805~xenobiotic metabolic process,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0009410~response to xenobiotic stimulus,GO:0009636~response to toxic substance,GO:0010468~regulation of gene expression,GO:0030522~intracellular receptor signaling pathway,GO:0030888~regulation of B cell proliferation,GO:0032922~circadian regulation of gene expression,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0034751~aryl hydrocarbon receptor complex,GO:0034752~cytosolic aryl hydrocarbon receptor complex,GO:0034753~nuclear aryl hydrocarbon receptor complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004874~aryl hydrocarbon receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0035326~enhancer binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0051879~Hsp90 protein binding,GO:0070888~E-box binding,	IPR000014:PAS domain,IPR001610:PAC motif,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR013655:PAS fold-3,IPR013767:PAS fold,				SM00086:PAC,SM00091:PAS,SM00353:HLH,	Acetylation,Activator,Biological rhythms,Cell cycle,Complete proteome,Cytoplasm,DNA-binding,Nucleus,Polymorphism,Receptor,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,	chain:Aryl hydrocarbon receptor,compositionally biased region:Gln-rich,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:PAC,domain:PAS 1,domain:PAS 2,mutagenesis site,sequence conflict,sequence variant,
CADH6_HUMAN	cadherin 6(CDH6)	Homo sapiens				GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007219~Notch signaling pathway,GO:0034332~adherens junction organization,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,	IPR000233:Cadherin, cytoplasmic domain,IPR002126:Cadherin,IPR015919:Cadherin-like,IPR020894:Cadherin conserved site,IPR027397:Catenin binding domain,				SM00112:CA,	Alternative splicing,Calcium,Cell adhesion,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Glycoprotein,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Cadherin-6,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CHST2_HUMAN	carbohydrate sulfotransferase 2(CHST2)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006044~N-acetylglucosamine metabolic process,GO:0006790~sulfur compound metabolic process,GO:0006954~inflammatory response,GO:0007275~multicellular organism development,GO:0018146~keratan sulfate biosynthetic process,	GO:0000139~Golgi membrane,GO:0005802~trans-Golgi network,GO:0016021~integral component of membrane,GO:0031228~intrinsic component of Golgi membrane,	GO:0001517~N-acetylglucosamine 6-O-sulfotransferase activity,GO:0008146~sulfotransferase activity,	IPR000863:Sulfotransferase domain,IPR016469:Carbohydrate sulfotransferase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00533:Glycosaminoglycan biosynthesis - keratan sulfate,		PIRSF005883:carbohydrate sulfotransferase,		Alternative initiation,Carbohydrate metabolism,Complete proteome,Disulfide bond,Glycoprotein,Golgi apparatus,Inflammatory response,Membrane,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Carbohydrate sulfotransferase 2,glycosylation site:N-linked (GlcNAc...),mutagenesis site,nucleotide phosphate-binding region:PAPS,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
CATB_HUMAN	cathepsin B(CTSB)	Homo sapiens				GO:0002224~toll-like receptor signaling pathway,GO:0006508~proteolysis,GO:0030574~collagen catabolic process,GO:0030855~epithelial cell differentiation,GO:0042981~regulation of apoptotic process,GO:0046697~decidualization,GO:0046718~viral entry into host cell,GO:0050790~regulation of catalytic activity,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0097067~cellular response to thyroid hormone stimulus,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005764~lysosome,GO:0036021~endolysosome lumen,GO:0042470~melanosome,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004197~cysteine-type endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016787~hydrolase activity,GO:0043394~proteoglycan binding,	IPR000169:Cysteine peptidase, cysteine active site,IPR000668:Peptidase C1A, papain C-terminal,IPR012599:Peptidase C1A, propeptide,IPR013128:Peptidase C1A, papain,IPR025660:Cysteine peptidase, histidine active site,IPR025661:Cysteine peptidase, asparagine active site,	hsa04142:Lysosome,hsa04612:Antigen processing and presentation,hsa04924:Renin secretion,			SM00645:Pept_C1,	3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Signal,Thiol protease,Zymogen,	chain:Cathepsin B,chain:Cathepsin B heavy chain,chain:Cathepsin B light chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,strand,turn,
CATL1_HUMAN	cathepsin L(CTSL)	Homo sapiens				GO:0002224~toll-like receptor signaling pathway,GO:0002250~adaptive immune response,GO:0006508~proteolysis,GO:0019882~antigen processing and presentation,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0022617~extracellular matrix disassembly,GO:0030574~collagen catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0071888~macrophage apoptotic process,GO:0097067~cellular response to thyroid hormone stimulus,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005764~lysosome,GO:0036021~endolysosome lumen,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,	GO:0001968~fibronectin binding,GO:0004197~cysteine-type endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0008234~cysteine-type peptidase activity,GO:0042393~histone binding,GO:0043394~proteoglycan binding,GO:0097655~serpin family protein binding,	IPR000169:Cysteine peptidase, cysteine active site,IPR000668:Peptidase C1A, papain C-terminal,IPR013128:Peptidase C1A, papain,IPR013201:Proteinase inhibitor I29, cathepsin propeptide,IPR025660:Cysteine peptidase, histidine active site,IPR025661:Cysteine peptidase, asparagine active site,	hsa04142:Lysosome,hsa04145:Phagosome,hsa04612:Antigen processing and presentation,hsa05205:Proteoglycans in cancer,hsa05323:Rheumatoid arthritis,			SM00645:Pept_C1,SM00848:SM00848,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Protease,Proteomics identification,Reference proteome,Signal,Thiol protease,Zymogen,	chain:Cathepsin L1 heavy chain,chain:Cathepsin L1 light chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Activation peptide,sequence conflict,signal peptide,strand,turn,
CATS_HUMAN	cathepsin S(CTSS)	Homo sapiens				GO:0002224~toll-like receptor signaling pathway,GO:0002250~adaptive immune response,GO:0006508~proteolysis,GO:0006955~immune response,GO:0010447~response to acidic pH,GO:0016485~protein processing,GO:0019882~antigen processing and presentation,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0022617~extracellular matrix disassembly,GO:0030574~collagen catabolic process,GO:0034769~basement membrane disassembly,GO:0048002~antigen processing and presentation of peptide antigen,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0097067~cellular response to thyroid hormone stimulus,GO:2001259~positive regulation of cation channel activity,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0036021~endolysosome lumen,GO:0043202~lysosomal lumen,GO:0043231~intracellular membrane-bounded organelle,	GO:0001968~fibronectin binding,GO:0004197~cysteine-type endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005518~collagen binding,GO:0008234~cysteine-type peptidase activity,GO:0043236~laminin binding,GO:0043394~proteoglycan binding,	IPR000169:Cysteine peptidase, cysteine active site,IPR000668:Peptidase C1A, papain C-terminal,IPR013128:Peptidase C1A, papain,IPR013201:Proteinase inhibitor I29, cathepsin propeptide,IPR025660:Cysteine peptidase, histidine active site,IPR025661:Cysteine peptidase, asparagine active site,	hsa04142:Lysosome,hsa04145:Phagosome,hsa04612:Antigen processing and presentation,hsa05152:Tuberculosis,			SM00645:Pept_C1,SM00848:SM00848,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal,Thiol protease,Zymogen,	chain:Cathepsin S,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,strand,turn,
CATZ_HUMAN	cathepsin Z(CTSZ)	Homo sapiens				GO:0002003~angiotensin maturation,GO:0006508~proteolysis,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0048208~COPII vesicle coating,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060441~epithelial tube branching involved in lung morphogenesis,	GO:0000139~Golgi membrane,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005886~plasma membrane,GO:0030134~ER to Golgi transport vesicle,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0004197~cysteine-type endopeptidase activity,GO:0005515~protein binding,GO:0008234~cysteine-type peptidase activity,	IPR000668:Peptidase C1A, papain C-terminal,IPR013128:Peptidase C1A, papain,IPR025661:Cysteine peptidase, asparagine active site,	hsa04142:Lysosome,			SM00645:Pept_C1,	3D-structure,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Polymorphism,Protease,Reference proteome,Signal,Thiol protease,Zymogen,	chain:Cathepsin Z,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,strand,turn,
CK096_HUMAN	chromosome 11 open reading frame 96(C11orf96)	Homo sapiens												Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein Ag2 homolog,compositionally biased region:Pro-rich,modified residue,sequence variant,
NMES1_HUMAN	chromosome 15 open reading frame 48(C15orf48)	Homo sapiens				GO:0055114~oxidation-reduction process,GO:1902600~hydrogen ion transmembrane transport,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005751~mitochondrial respiratory chain complex IV,GO:0016021~integral component of membrane,	GO:0004129~cytochrome-c oxidase activity,GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR010530:NADH-ubiquinone reductase complex 1 MLRQ subunit,					Complete proteome,Membrane,Nucleus,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Normal mucosa of esophagus-specific gene 1 protein,
TF_HUMAN	coagulation factor III, tissue factor(F3)	Homo sapiens		h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway,		GO:0001938~positive regulation of endothelial cell proliferation,GO:0002541~activation of plasma proteins involved in acute inflammatory response,GO:0002543~activation of blood coagulation via clotting cascade,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007596~blood coagulation,GO:0007598~blood coagulation, extrinsic pathway,GO:0010641~positive regulation of platelet-derived growth factor receptor signaling pathway,GO:0016485~protein processing,GO:0019221~cytokine-mediated signaling pathway,GO:0030335~positive regulation of cell migration,GO:0045766~positive regulation of angiogenesis,GO:0050927~positive regulation of positive chemotaxis,GO:0051897~positive regulation of protein kinase B signaling,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,GO:0031233~intrinsic component of external side of plasma membrane,GO:0070062~extracellular exosome,GO:1905286~serine-type peptidase complex,	GO:0002020~protease binding,GO:0004252~serine-type endopeptidase activity,GO:0004896~cytokine receptor activity,GO:0005515~protein binding,GO:0005543~phospholipid binding,	IPR001187:Tissue factor,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR015373:Interferon alpha/beta receptor, beta chain,IPR016354:Tissue factor/coagulation factor III,	hsa04610:Complement and coagulation cascades,		PIRSF002498:tissue factor/coagulation factor III,		3D-structure,Alternative splicing,Blood coagulation,Complete proteome,Disulfide bond,Glycoprotein,Hemostasis,Lipoprotein,Membrane,Palmitate,Polymorphism,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:tissue factor,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:S-palmitoyl cysteine,sequence conflict,sequence variant,short sequence motif:WKS motif,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CO4A2_HUMAN	collagen type IV alpha 2 chain(COL4A2)	Homo sapiens		h_ace2Pathway:Angiotensin-converting enzyme 2 regulates heart function,h_amiPathway:Acute Myocardial Infarction,h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway,h_npp1Pathway:Regulators of Bone Mineralization,h_plateletAppPathway:Platelet Amyloid Precursor Protein Pathway,h_vitCBPathway:Vitamin C in the Brain,		GO:0001525~angiogenesis,GO:0006351~transcription, DNA-templated,GO:0016525~negative regulation of angiogenesis,GO:0030198~extracellular matrix organization,GO:0030574~collagen catabolic process,GO:0035987~endodermal cell differentiation,GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway,GO:0071560~cellular response to transforming growth factor beta stimulus,	GO:0005576~extracellular region,GO:0005587~collagen type IV trimer,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,	IPR001442:Collagen IV, non-collagenous,IPR008160:Collagen triple helix repeat,IPR016187:C-type lectin fold,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04974:Protein digestion and absorption,hsa05146:Amoebiasis,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	614483~Porencephaly 2,614519~Hemorrhage, intracerebral, susceptibility to,		SM00111:C4,	3D-structure,Angiogenesis,Basement membrane,Collagen,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Extracellular matrix,Glycoprotein,Hydroxylation,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Canstatin,chain:Collagen alpha-2(IV) chain,disulfide bond,domain:Collagen IV NC1,glycosylation site:N-linked (GlcNAc...),helix,propeptide:N-terminal propeptide (7S domain),region of interest:Triple-helical region,sequence conflict,sequence variant,signal peptide,strand,turn,
CO5A1_HUMAN	collagen type V alpha 1 chain(COL5A1)	Homo sapiens				GO:0001568~blood vessel development,GO:0003007~heart morphogenesis,GO:0007155~cell adhesion,GO:0016477~cell migration,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030574~collagen catabolic process,GO:0032964~collagen biosynthetic process,GO:0035313~wound healing, spreading of epidermal cells,GO:0035989~tendon development,GO:0043206~extracellular fibril organization,GO:0043588~skin development,GO:0045112~integrin biosynthetic process,GO:0048592~eye morphogenesis,GO:0051128~regulation of cellular component organization,GO:1903225~negative regulation of endodermal cell differentiation,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005588~collagen type V trimer,GO:0005604~basement membrane,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0005178~integrin binding,GO:0005201~extracellular matrix structural constituent,GO:0008201~heparin binding,GO:0043394~proteoglycan binding,GO:0046872~metal ion binding,GO:0048407~platelet-derived growth factor binding,	IPR000885:Fibrillar collagen, C-terminal,IPR001791:Laminin G domain,IPR008160:Collagen triple helix repeat,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04611:Platelet activation,hsa04974:Protein digestion and absorption,hsa05146:Amoebiasis,	130000~Ehlers-Danlos syndrome, classic type,		SM00038:COLFI,SM00210:TSPN,SM00282:LamG,	3D-structure,Calcium,Collagen,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Ehlers-Danlos syndrome,Extracellular matrix,Heparin-binding,Hydroxylation,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sulfation,	chain:Collagen alpha-1(V) chain,domain:Fibrillar collagen NC1,domain:Laminin G-like,domain:TSP N-terminal,modified residue,propeptide:C-terminal propeptide,region of interest:Interrupted collagenous region,region of interest:Nonhelical region,region of interest:Triple-helical region,sequence conflict,sequence variant,signal peptide,
CO7A1_HUMAN	collagen type VII alpha 1 chain(COL7A1)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007155~cell adhesion,GO:0008544~epidermis development,GO:0010951~negative regulation of endopeptidase activity,GO:0030198~extracellular matrix organization,GO:0030574~collagen catabolic process,GO:0035987~endodermal cell differentiation,GO:0048208~COPII vesicle coating,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005590~collagen type VII trimer,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0030134~ER to Golgi transport vesicle,GO:0031012~extracellular matrix,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR002035:von Willebrand factor, type A,IPR002223:Proteinase inhibitor I2, Kunitz metazoa,IPR003961:Fibronectin, type III,IPR008160:Collagen triple helix repeat,IPR013783:Immunoglobulin-like fold,IPR020901:Proteinase inhibitor I2, Kunitz, conserved site,	hsa04974:Protein digestion and absorption,	131705~Transient bullous of the newborn,131750~Epidermolysis bullosa dystrophica, AD,131850~Epidermolysis bullosa, pretibial,132000~EBD, Bart type,226600~EBD inversa,226600~Epidermolysis bullosa dystrophica, AR,604129~Epidermolysis bullosa pruriginosa,607523~Toenail dystrophy, isolated,EBD, localisata variant~EBD, localisata variant,		SM00060:FN3,SM00327:VWA,	Alternative splicing,Basement membrane,Cell adhesion,Collagen,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Epidermolysis bullosa,Extracellular matrix,Glycoprotein,Hydroxylation,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease inhibitor,Signal,	chain:Collagen alpha-1(VII) chain,disulfide bond,domain:BPTI/Kunitz inhibitor,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Fibronectin type-III 9,domain:VWFA 1,domain:VWFA 2,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Gal...),modified residue,region of interest:Interrupted collagenous region,region of interest:Nonhelical region (NC1),region of interest:Nonhelical region (NC2),region of interest:Triple-helical region,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,site:Reactive bond,splice variant,
CYTC_HUMAN	cystatin C(CST3)	Homo sapiens				GO:0001654~eye development,GO:0001666~response to hypoxia,GO:0001775~cell activation,GO:0006915~apoptotic process,GO:0006952~defense response,GO:0007420~brain development,GO:0007431~salivary gland development,GO:0007566~embryo implantation,GO:0008284~positive regulation of cell proliferation,GO:0009636~response to toxic substance,GO:0009743~response to carbohydrate,GO:0010466~negative regulation of peptidase activity,GO:0010711~negative regulation of collagen catabolic process,GO:0010716~negative regulation of extracellular matrix disassembly,GO:0031667~response to nutrient levels,GO:0032355~response to estradiol,GO:0034103~regulation of tissue remodeling,GO:0042493~response to drug,GO:0042747~circadian sleep/wake cycle, REM sleep,GO:0043067~regulation of programmed cell death,GO:0043206~extracellular fibril organization,GO:0044267~cellular protein metabolic process,GO:0045740~positive regulation of DNA replication,GO:0045861~negative regulation of proteolysis,GO:0048678~response to axon injury,GO:0060009~Sertoli cell development,GO:0060311~negative regulation of elastin catabolic process,GO:0060313~negative regulation of blood vessel remodeling,GO:0060548~negative regulation of cell death,GO:0070301~cellular response to hydrogen peroxide,GO:2000117~negative regulation of cysteine-type endopeptidase activity,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005771~multivesicular body,GO:0005783~endoplasmic reticulum,GO:0030424~axon,GO:0031965~nuclear membrane,GO:0031982~vesicle,GO:0043025~neuronal cell body,GO:0043292~contractile fiber,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0001540~beta-amyloid binding,GO:0002020~protease binding,GO:0004866~endopeptidase inhibitor activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000010:Proteinase inhibitor I25, cystatin,IPR018073:Proteinase inhibitor I25, cystatin, conserved site,IPR027214:Cystatin,	hsa04970:Salivary secretion,	105150~Cerebral amyloid angiopathy,611953~Macular degeneration, age-related, 11,		SM00043:CY,	3D-structure,Age-related macular degeneration,Amyloid,Amyloidosis,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Phosphoprotein,Polymorphism,Protease inhibitor,Reference proteome,Secreted,Signal,Thiol protease inhibitor,	chain:Cystatin-C,disulfide bond,helix,mutagenesis site,sequence variant,short sequence motif:Secondary area of contact,signal peptide,site:Reactive site,strand,turn,
CP2S1_HUMAN	cytochrome P450 family 2 subfamily S member 1(CYP2S1)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism,	GO:0055114~oxidation-reduction process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,	GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0008395~steroid hydroxylase activity,GO:0008401~retinoic acid 4-hydroxylase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0020037~heme binding,GO:0070330~aromatase activity,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR008067:Cytochrome P450, E-class, group I, CYP2A-like,IPR017972:Cytochrome P450, conserved site,	hsa00830:Retinol metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Heme,Iron,Membrane,Metal-binding,Microsome,Monooxygenase,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Cytochrome P450 2S1,metal ion-binding site:Iron (heme axial ligand),sequence variant,splice variant,
CPEB4_HUMAN	cytoplasmic polyadenylation element binding protein 4(CPEB4)	Homo sapiens				GO:0002931~response to ischemia,GO:0006412~translation,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0036294~cellular response to decreased oxygen levels,GO:0042149~cellular response to glucose starvation,GO:0043524~negative regulation of neuron apoptotic process,GO:0071230~cellular response to amino acid stimulus,GO:2000766~negative regulation of cytoplasmic translation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0030425~dendrite,GO:0043005~neuron projection,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:1990124~messenger ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0000900~translation repressor activity, nucleic acid binding,GO:0003676~nucleic acid binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008135~translation factor activity, RNA binding,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa04114:Oocyte meiosis,hsa04320:Dorso-ventral axis formation,hsa04914:Progesterone-mediated oocyte maturation,			SM00360:RRM,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Cell projection,Complete proteome,Membrane,Phosphoprotein,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Repeat,RNA-binding,Synapse,	chain:Cytoplasmic polyadenylation element- binding protein 4,compositionally biased region:His-rich,compositionally biased region:Poly-Gly,domain:RRM 1,domain:RRM 2,modified residue,sequence conflict,splice variant,
DCP2_HUMAN	decapping mRNA 2(DCP2)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000290~deadenylation-dependent decapping of nuclear-transcribed mRNA,GO:0006402~mRNA catabolic process,GO:0043488~regulation of mRNA stability,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0071044~histone mRNA catabolic process,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,	GO:0000932~cytoplasmic mRNA processing body,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016442~RISC complex,GO:0030054~cell junction,GO:0043231~intracellular membrane-bounded organelle,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0016896~exoribonuclease activity, producing 5'-phosphomonoesters,GO:0030145~manganese ion binding,GO:0050072~m7G(5')pppN diphosphatase activity,	IPR000086:NUDIX hydrolase domain,IPR007722:mRNA decapping protein 2, Box A,IPR015797:NUDIX hydrolase domain-like,IPR020084:NUDIX hydrolase, conserved site,	hsa03018:RNA degradation,			SM01125:SM01125,	Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Manganese,Metal-binding,Nonsense-mediated mRNA decay,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:mRNA-decapping enzyme 2,domain:Nudix hydrolase,metal ion-binding site:Manganese,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:Nudix box,splice variant,
DOCK4_HUMAN	dedicator of cytokinesis 4(DOCK4)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0060326~cell chemotaxis,GO:1904694~negative regulation of vascular smooth muscle contraction,GO:1904754~positive regulation of vascular associated smooth muscle cell migration,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0032420~stereocilium,GO:0032421~stereocilium bundle,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0030165~PDZ domain binding,GO:0030971~receptor tyrosine kinase binding,GO:0048365~Rac GTPase binding,	IPR001452:Src homology-3 domain,IPR010703:Dedicator of cytokinesis C-terminal,IPR011511:Variant SH3,IPR026791:Dedicator of cytokinesis,IPR027007:DHR-1 domain,IPR027357:DHR-2 domain,	hsa04015:Rap1 signaling pathway,			SM00326:SH3,	Alternative splicing,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,SH3 domain,SH3-binding,	chain:Dedicator of cytokinesis protein 4,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,domain:DHR-1,domain:DHR-2,domain:SH3,modified residue,sequence conflict,sequence variant,short sequence motif:SH3-binding,splice variant,
DOCK6_HUMAN	dedicator of cytokinesis 6(DOCK6)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0007596~blood coagulation,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0005085~guanyl-nucleotide exchange factor activity,	IPR010703:Dedicator of cytokinesis C-terminal,IPR021816:Dedicator of cytokinesis C/D, N-terminal,IPR026791:Dedicator of cytokinesis,IPR026798:Dedicator of cytokinesis C,IPR027007:DHR-1 domain,IPR027357:DHR-2 domain,		614219~Adams-Oliver syndrome 2,			Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Dedicator of cytokinesis protein 6,domain:DHR-1,domain:DHR-2,modified residue,sequence variant,
DCNL5_HUMAN	defective in cullin neddylation 1 domain containing 5(DCUN1D5)	Homo sapiens				GO:0045116~protein neddylation,GO:0051443~positive regulation of ubiquitin-protein transferase activity,	GO:0000151~ubiquitin ligase complex,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0031624~ubiquitin conjugating enzyme binding,GO:0032182~ubiquitin-like protein binding,GO:0097602~cullin family protein binding,	IPR005176:Potentiating neddylation domain,IPR014764:Defective-in-cullin neddylation protein,					Complete proteome,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:DCN1-like protein 5,domain:DCUN1,modified residue,sequence conflict,
DUS1_HUMAN	dual specificity phosphatase 1(DUSP1)	Homo sapiens		h_cd40Pathway:CD40L Signaling Pathway,h_dspPathway:Regulation of MAP Kinase Pathways Through Dual Specificity Phosphatases,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_tnfr2Pathway:TNFR2 Signaling Pathway,		GO:0000188~inactivation of MAPK activity,GO:0001706~endoderm formation,GO:0006979~response to oxidative stress,GO:0009416~response to light stimulus,GO:0032355~response to estradiol,GO:0032526~response to retinoic acid,GO:0032870~cellular response to hormone stimulus,GO:0033574~response to testosterone,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0035556~intracellular signal transduction,GO:0035970~peptidyl-threonine dephosphorylation,GO:0042542~response to hydrogen peroxide,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043407~negative regulation of MAP kinase activity,GO:0043409~negative regulation of MAPK cascade,GO:0051384~response to glucocorticoid,GO:0051447~negative regulation of meiotic cell cycle,GO:0051591~response to cAMP,GO:0051592~response to calcium ion,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0071850~mitotic cell cycle arrest,GO:0090266~regulation of mitotic cell cycle spindle assembly checkpoint,GO:2000279~negative regulation of DNA biosynthetic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004725~protein tyrosine phosphatase activity,GO:0004726~non-membrane spanning protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0008330~protein tyrosine/threonine phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,GO:0019838~growth factor binding,	IPR000340:Dual specificity phosphatase, catalytic domain,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR001763:Rhodanese-like domain,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR008343:Mitogen-activated protein (MAP) kinase phosphatase,IPR016130:Protein-tyrosine phosphatase, active site,IPR020417:Atypical dual specificity phosphatase,IPR020422:Dual specificity phosphatase, subgroup, catalytic domain,IPR024950:Dual specificity phosphatase,	hsa04010:MAPK signaling pathway,		PIRSF000939:dual specificity protein phosphatase (MAP kinase phosphatase),	SM00195:DSPc,SM00404:PTPc_motif,SM00450:RHOD,	Cell cycle,Complete proteome,Hydrolase,Nucleus,Phosphoprotein,Polymorphism,Protein phosphatase,Reference proteome,Stress response,	active site:Phosphocysteine intermediate,chain:Dual specificity protein phosphatase 1,domain:Rhodanese,domain:Tyrosine-protein phosphatase,sequence variant,
ENC1_HUMAN	ectodermal-neural cortex 1(ENC1)	Homo sapiens				GO:0007275~multicellular organism development,GO:0007399~nervous system development,GO:0010499~proteasomal ubiquitin-independent protein catabolic process,GO:0010976~positive regulation of neuron projection development,GO:0016567~protein ubiquitination,GO:0017148~negative regulation of translation,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0016363~nuclear matrix,GO:0031463~Cul3-RING ubiquitin ligase complex,GO:0043025~neuronal cell body,	GO:0003779~actin binding,GO:0005515~protein binding,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015915:Kelch-type beta propeller,IPR017096:Kelch-like protein, gigaxonin,			PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	Actin-binding,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Kelch repeat,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	chain:Ectoderm-neural cortex protein 1,domain:BTB,modified residue,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,sequence conflict,sequence variant,
ERO1B_HUMAN	endoplasmic reticulum oxidoreductase 1 beta(ERO1B)	Homo sapiens				GO:0006457~protein folding,GO:0006464~cellular protein modification process,GO:0019471~4-hydroxyproline metabolic process,GO:0022417~protein maturation by protein folding,GO:0030070~insulin processing,GO:0030198~extracellular matrix organization,GO:0034975~protein folding in endoplasmic reticulum,GO:0042593~glucose homeostasis,GO:0045454~cell redox homeostasis,GO:0055114~oxidation-reduction process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,	GO:0003756~protein disulfide isomerase activity,GO:0005515~protein binding,GO:0015035~protein disulfide oxidoreductase activity,GO:0016491~oxidoreductase activity,GO:0016671~oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,GO:0051082~unfolded protein binding,	IPR007266:Endoplasmic reticulum oxidoreductin 1,	hsa04141:Protein processing in endoplasmic reticulum,		PIRSF017205:endoplasmic oxidoreductin,		Alternative splicing,Complete proteome,Disulfide bond,Electron transport,Endoplasmic reticulum,FAD,Flavoprotein,Glycoprotein,Membrane,Oxidoreductase,Polymorphism,Proteomics identification,Redox-active center,Reference proteome,Signal,Transport,	binding site:FAD,chain:ERO1-like protein beta,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
ESR1_HUMAN	estrogen receptor 1(ESR1)	Homo sapiens		h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_mta3Pathway:Downregulated of MTA-3 in ER-negative Breast Tumors,h_pelp1Pathway:Pelp1 Modulation of Estrogen Receptor Activity,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001547~antral ovarian follicle growth,GO:0002064~epithelial cell development,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0008209~androgen metabolic process,GO:0008584~male gonad development,GO:0010629~negative regulation of gene expression,GO:0010863~positive regulation of phospholipase C activity,GO:0030518~intracellular steroid hormone receptor signaling pathway,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0032355~response to estradiol,GO:0034121~regulation of toll-like receptor signaling pathway,GO:0042981~regulation of apoptotic process,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043401~steroid hormone mediated signaling pathway,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043627~response to estrogen,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048146~positive regulation of fibroblast proliferation,GO:0050727~regulation of inflammatory response,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060065~uterus development,GO:0060068~vagina development,GO:0060523~prostate epithelial cord elongation,GO:0060527~prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,GO:0060687~regulation of branching involved in prostate gland morphogenesis,GO:0060745~mammary gland branching involved in pregnancy,GO:0060749~mammary gland alveolus development,GO:0060750~epithelial cell proliferation involved in mammary gland duct elongation,GO:0071168~protein localization to chromatin,GO:0071391~cellular response to estrogen stimulus,GO:0071392~cellular response to estradiol stimulus,GO:1903799~negative regulation of production of miRNAs involved in gene silencing by miRNA,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0035327~transcriptionally active chromatin,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005496~steroid binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0030235~nitric-oxide synthase regulator activity,GO:0030284~estrogen receptor activity,GO:0034056~estrogen response element binding,GO:0038052~RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0051117~ATPase binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001292:Oestrogen receptor,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR013088:Zinc finger, NHR/GATA-type,IPR024178:Oestrogen receptor/oestrogen-related receptor,IPR024736:Oestrogen-type nuclear receptor final C-terminal domain,	hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa05205:Proteoglycans in cancer,	114480~Breast cancer,157300~Migraine, susceptibility to,608446~Myocardial infarction, susceptibility to,615363~Estrogen resistance,Atherosclerosis, susceptibility to~Atherosclerosis, susceptibility to,HDL response to hormone replacement, augmented~HDL response to hormone replacement, augmented,	PIRSF002527:estrogen receptor-like nuclear receptor,PIRSF500101:estrogen receptor alpha [Parent=PIRSF002527],	SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Activator,Alternative promoter usage,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,DNA-binding,Glycoprotein,Golgi apparatus,Lipid-binding,Lipoprotein,Membrane,Metal-binding,Methylation,Nucleus,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Steroid-binding,Transcription,Transcription regulation,Transmembrane,Ubl conjugation,Zinc,Zinc-finger,	chain:Estrogen receptor,DNA-binding region:Nuclear receptor,glycosylation site:O-linked (GlcNAc),helix,modified residue,mutagenesis site,region of interest:Hinge,region of interest:Interaction with AKAP13,region of interest:Mediates interaction with DNTTIP2,region of interest:Modulating; mediates interaction with MACROD1,region of interest:Steroid-binding,sequence variant,splice variant,strand,turn,zinc finger region:NR C4-type,
FGF2_HUMAN	fibroblast growth factor 2(FGF2)	Homo sapiens		h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),		GO:0000165~MAPK cascade,GO:0000186~activation of MAPKK activity,GO:0000187~activation of MAPK activity,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001759~organ induction,GO:0001938~positive regulation of endothelial cell proliferation,GO:0002042~cell migration involved in sprouting angiogenesis,GO:0006661~phosphatidylinositol biosynthetic process,GO:0006935~chemotaxis,GO:0007165~signal transduction,GO:0007265~Ras protein signal transduction,GO:0007399~nervous system development,GO:0007568~aging,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0009792~embryo development ending in birth or egg hatching,GO:0009887~organ morphogenesis,GO:0010001~glial cell differentiation,GO:0010595~positive regulation of endothelial cell migration,GO:0010764~negative regulation of fibroblast migration,GO:0010863~positive regulation of phospholipase C activity,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0014843~growth factor dependent regulation of skeletal muscle satellite cell proliferation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021762~substantia nigra development,GO:0021940~positive regulation of cerebellar granule cell precursor proliferation,GO:0030198~extracellular matrix organization,GO:0030214~hyaluronan catabolic process,GO:0030324~lung development,GO:0031334~positive regulation of protein complex assembly,GO:0032958~inositol phosphate biosynthetic process,GO:0035019~somatic stem cell population maintenance,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0042060~wound healing,GO:0042660~positive regulation of cell fate specification,GO:0043406~positive regulation of MAP kinase activity,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0043537~negative regulation of blood vessel endothelial cell migration,GO:0043547~positive regulation of GTPase activity,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045669~positive regulation of osteoblast differentiation,GO:0045765~regulation of angiogenesis,GO:0045766~positive regulation of angiogenesis,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046668~regulation of retinal cell programmed cell death,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048598~embryonic morphogenesis,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048678~response to axon injury,GO:0048864~stem cell development,GO:0050918~positive chemotaxis,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051726~regulation of cell cycle,GO:0051781~positive regulation of cell division,GO:0051897~positive regulation of protein kinase B signaling,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0060128~corticotropin hormone secreting cell differentiation,GO:0060129~thyroid-stimulating hormone-secreting cell differentiation,GO:0060548~negative regulation of cell death,GO:0060591~chondroblast differentiation,GO:0060644~mammary gland epithelial cell differentiation,GO:0060978~angiogenesis involved in coronary vascular morphogenesis,GO:0061045~negative regulation of wound healing,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1903672~positive regulation of sprouting angiogenesis,GO:2000544~regulation of endothelial cell chemotaxis to fibroblast growth factor,GO:2000546~positive regulation of endothelial cell chemotaxis to fibroblast growth factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004713~protein tyrosine kinase activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005104~fibroblast growth factor receptor binding,GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0042056~chemoattractant activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR002209:Heparin-binding growth factor/Fibroblast growth factor,IPR008996:Cytokine, IL-1-like,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05218:Melanoma,			SM00442:FGF,	3D-structure,Alternative initiation,Angiogenesis,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Growth factor,Heparin-binding,Isopeptide bond,Methylation,Mitogen,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Secreted,Ubl conjugation,	binding site:Heparin,chain:Heparin-binding growth factor 2,helix,propeptide:Or 93, or 124, or 125, or 131, or 161,region of interest:Heparin-binding,sequence conflict,short sequence motif:Cell attachment site; atypical,splice variant,strand,turn,
FLRT3_HUMAN	fibronectin leucine rich transmembrane protein 3(FLRT3)	Homo sapiens				GO:0003345~proepicardium cell migration involved in pericardium morphogenesis,GO:0006469~negative regulation of protein kinase activity,GO:0007411~axon guidance,GO:0007416~synapse assembly,GO:0007507~heart development,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0019221~cytokine-mediated signaling pathway,GO:0031175~neuron projection development,GO:0046426~negative regulation of JAK-STAT cascade,GO:0048598~embryonic morphogenesis,GO:0048678~response to axon injury,GO:0050919~negative chemotaxis,GO:0051965~positive regulation of synapse assembly,GO:0060322~head development,GO:0098609~cell-cell adhesion,GO:1990138~neuron projection extension,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0043679~axon terminus,GO:0044295~axonal growth cone,GO:0097060~synaptic membrane,	GO:0004860~protein kinase inhibitor activity,GO:0005057~receptor signaling protein activity,GO:0005104~fibroblast growth factor receptor binding,GO:0005515~protein binding,GO:0030674~protein binding, bridging,GO:0042803~protein homodimerization activity,GO:0045499~chemorepellent activity,	IPR000372:Leucine-rich repeat-containing N-terminal,IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR003961:Fibronectin, type III,		615271~Hypogonadotropic hypogonadism 21 with anosmia,		SM00013:LRRNT,SM00082:LRRCT,SM00369:LRR_TYP,	3D-structure,Cell adhesion,Cell junction,Cell membrane,Cell projection,Complete proteome,Developmental protein,Disease mutation,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Hypogonadotropic hypogonadism,Kallmann syndrome,Leucine-rich repeat,Membrane,Polymorphism,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Leucine-rich repeat transmembrane protein FLRT3,domain:Fibronectin type-III,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:LRR 1,repeat:LRR 10,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
VGFR1_HUMAN	fms related tyrosine kinase 1(FLT1)	Homo sapiens		h_no1Pathway:Actions of Nitric Oxide in the Heart,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0001525~angiogenesis,GO:0002548~monocyte chemotaxis,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0010863~positive regulation of phospholipase C activity,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030154~cell differentiation,GO:0030335~positive regulation of cell migration,GO:0030949~positive regulation of vascular endothelial growth factor receptor signaling pathway,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0036323~vascular endothelial growth factor receptor-1 signaling pathway,GO:0038084~vascular endothelial growth factor signaling pathway,GO:0043406~positive regulation of MAP kinase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045766~positive regulation of angiogenesis,GO:0046777~protein autophosphorylation,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048514~blood vessel morphogenesis,GO:0048598~embryonic morphogenesis,	GO:0005615~extracellular space,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0043235~receptor complex,	GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005021~vascular endothelial growth factor-activated receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019838~growth factor binding,GO:0036326~VEGF-A-activated receptor activity,GO:0036327~VEGF-B-activated receptor activity,GO:0036332~placental growth factor-activated receptor activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001824:Tyrosine-protein kinase, receptor class III, conserved site,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR009135:Tyrosine-protein kinase, vascular endothelial growth factor receptor 1 (VEGFR1), N-terminal,IPR009137:Tyrosine-protein kinase, vascular endothelial growth factor receptor 3 (VEGFR3), N-terminal,IPR011009:Protein kinase-like domain,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa05202:Transcriptional misregulation in cancer,hsa05323:Rheumatoid arthritis,			SM00219:TyrKc,SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Angiogenesis,ATP-binding,Cell membrane,Chemotaxis,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Direct protein sequencing,Disulfide bond,Endosome,Glycoprotein,Immunoglobulin domain,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Vascular endothelial growth factor receptor 1,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
AGAL_HUMAN	galactosidase alpha(GLA)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006687~glycosphingolipid metabolic process,GO:0009311~oligosaccharide metabolic process,GO:0045019~negative regulation of nitric oxide biosynthetic process,GO:0046477~glycosylceramide catabolic process,GO:0046479~glycosphingolipid catabolic process,GO:0051001~negative regulation of nitric-oxide synthase activity,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005794~Golgi apparatus,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0004557~alpha-galactosidase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0016936~galactoside binding,GO:0042803~protein homodimerization activity,GO:0052692~raffinose alpha-galactosidase activity,	IPR000111:Glycoside hydrolase, clan GH-D,IPR002241:Glycoside hydrolase, family 27,IPR013780:Glycosyl hydrolase, family 13, all-beta,IPR013785:Aldolase-type TIM barrel,IPR017853:Glycoside hydrolase, superfamily,	hsa00052:Galactose metabolism,hsa00561:Glycerolipid metabolism,hsa00600:Sphingolipid metabolism,hsa00603:Glycosphingolipid biosynthesis - globo series,hsa04142:Lysosome,	301500~Fabry disease,301500~Fabry disease, cardiac variant,			3D-structure,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Glycosidase,Hydrolase,Lysosome,Pharmaceutical,Proteomics identification,Reference proteome,RNA editing,Signal,	active site:Nucleophile,active site:Proton donor,chain:Alpha-galactosidase A,chain:alpha-galactosidase A subunit peptide,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Substrate binding,sequence variant,signal peptide,strand,turn,
G5E9Z6_HUMAN	gamma-aminobutyric acid type A receptor alpha2 subunit(GABRA2)	Homo sapiens		h_FlumazenilPathway:Cardiac Protection Against ROS ,h_gabaPathway:Gamma-aminobutyric Acid Receptor Life Cycle,		GO:0001505~regulation of neurotransmitter levels,GO:0006811~ion transport,GO:0006821~chloride transport,GO:0006836~neurotransmitter transport,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0034220~ion transmembrane transport,GO:1902476~chloride transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030285~integral component of synaptic vesicle membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0034707~chloride channel complex,GO:0043025~neuronal cell body,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0060077~inhibitory synapse,GO:0098794~postsynapse,GO:1902711~GABA-A receptor complex,	GO:0004890~GABA-A receptor activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0008503~benzodiazepine receptor activity,GO:0022851~GABA-gated chloride ion channel activity,	IPR001390:Gamma-aminobutyric-acid A receptor, alpha subunit,IPR005432:Gamma-aminobutyric-acid A receptor, alpha 2 subunit,IPR006028:Gamma-aminobutyric acid A receptor,IPR006029:Neurotransmitter-gated ion-channel transmembrane domain,IPR006201:Neurotransmitter-gated ion-channel,IPR006202:Neurotransmitter-gated ion-channel ligand-binding,IPR018000:Neurotransmitter-gated ion-channel, conserved site,	hsa04080:Neuroactive ligand-receptor interaction,hsa04723:Retrograde endocannabinoid signaling,hsa04727:GABAergic synapse,hsa05032:Morphine addiction,hsa05033:Nicotine addiction,	103780~Alcohol dependence, susceptibility to,			Alternative splicing,Cell junction,Cell membrane,Chloride,Chloride channel,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Postsynaptic cell membrane,Proteomics identification,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Gamma-aminobutyric acid receptor subunit alpha-2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GFPT2_HUMAN	glutamine-fructose-6-phosphate transaminase 2(GFPT2)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006002~fructose 6-phosphate metabolic process,GO:0006047~UDP-N-acetylglucosamine metabolic process,GO:0006048~UDP-N-acetylglucosamine biosynthetic process,GO:0006112~energy reserve metabolic process,GO:0006541~glutamine metabolic process,GO:1901137~carbohydrate derivative biosynthetic process,	GO:0005829~cytosol,	GO:0004360~glutamine-fructose-6-phosphate transaminase (isomerizing) activity,GO:0005515~protein binding,GO:0030246~carbohydrate binding,	IPR001347:Sugar isomerase (SIS),IPR005855:Glucosamine-fructose-6-phosphate aminotransferase, isomerising,IPR017932:Glutamine amidotransferase type 2 domain,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa04931:Insulin resistance,				Aminotransferase,Complete proteome,Glutamine amidotransferase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transferase,	active site:For GATase activity,chain:Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 2,domain:Glutamine amidotransferase type-2,domain:SIS 1,domain:SIS 2,modified residue,sequence variant,
GLPK2_HUMAN	glycerol kinase 2(GK2)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006071~glycerol metabolic process,GO:0006072~glycerol-3-phosphate metabolic process,GO:0006641~triglyceride metabolic process,GO:0016310~phosphorylation,GO:0019563~glycerol catabolic process,GO:0046167~glycerol-3-phosphate biosynthetic process,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0070062~extracellular exosome,	GO:0004370~glycerol kinase activity,GO:0005524~ATP binding,	IPR005999:Glycerol kinase,IPR018483:Carbohydrate kinase, FGGY, conserved site,IPR018484:Carbohydrate kinase, FGGY, N-terminal,IPR018485:Carbohydrate kinase, FGGY, C-terminal,	hsa00561:Glycerolipid metabolism,hsa01100:Metabolic pathways,hsa03320:PPAR signaling pathway,		PIRSF000538:keto-sugar kinase,		ATP-binding,Complete proteome,Cytoplasm,Glycerol metabolism,Kinase,Membrane,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Reference proteome,Transferase,	binding site:ATP,binding site:ATP; via carbonyl oxygen,binding site:Substrate,chain:Glycerol kinase 2,nucleotide phosphate-binding region:ATP,sequence conflict,
GLPK_HUMAN	glycerol kinase(GK)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006071~glycerol metabolic process,GO:0006641~triglyceride metabolic process,GO:0016310~phosphorylation,GO:0019432~triglyceride biosynthetic process,GO:0019563~glycerol catabolic process,GO:0046167~glycerol-3-phosphate biosynthetic process,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004370~glycerol kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,	IPR005999:Glycerol kinase,IPR018483:Carbohydrate kinase, FGGY, conserved site,IPR018484:Carbohydrate kinase, FGGY, N-terminal,IPR018485:Carbohydrate kinase, FGGY, C-terminal,	hsa00561:Glycerolipid metabolism,hsa01100:Metabolic pathways,hsa03320:PPAR signaling pathway,	307030~Glycerol kinase deficiency,	PIRSF000538:keto-sugar kinase,		Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Disease mutation,Glycerol metabolism,Kinase,Membrane,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transferase,	binding site:ATP,binding site:ATP; via carbonyl oxygen,binding site:Substrate,chain:Glycerol kinase,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
GOPC_HUMAN	golgi associated PDZ and coiled-coil motif containing(GOPC)	Homo sapiens			General function prediction only,	GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006893~Golgi to plasma membrane transport,GO:0007289~spermatid nucleus differentiation,GO:0015031~protein transport,GO:0043004~cytoplasmic sequestering of CFTR protein,GO:0045176~apical protein localization,GO:0051260~protein homooligomerization,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030054~cell junction,GO:0030140~trans-Golgi network transport vesicle,GO:0030425~dendrite,GO:0030660~Golgi-associated vesicle membrane,GO:0043234~protein complex,GO:0045211~postsynaptic membrane,	GO:0005515~protein binding,GO:0030695~GTPase regulator activity,GO:0044325~ion channel binding,	IPR001478:PDZ domain,				SM00228:PDZ,	3D-structure,Acetylation,Alternative splicing,Cell junction,Cell membrane,Cell projection,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Golgi apparatus,Membrane,Postsynaptic cell membrane,Protein transport,Proteomics identification,Reference proteome,Synapse,Transport,	chain:Golgi-associated PDZ and coiled-coil motif-containing protein,domain:PDZ,helix,modified residue,mutagenesis site,site:Breakpoint for translocation to form GOPC-ROS1 fusion protein,splice variant,strand,
GDF15_HUMAN	growth differentiation factor 15(GDF15)	Homo sapiens				GO:0007165~signal transduction,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0042981~regulation of apoptotic process,GO:0043408~regulation of MAPK cascade,GO:0048468~cell development,GO:0060395~SMAD protein signal transduction,GO:1901741~positive regulation of myoblast fusion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,	IPR001839:Transforming growth factor-beta, C-terminal,IPR015615:Transforming growth factor-beta-related,				SM00204:TGFB,	Cleavage on pair of basic residues,Complete proteome,Cytokine,Disulfide bond,Glycoprotein,Growth factor,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Growth/differentiation factor 15,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
HS74L_HUMAN	heat shock protein family A (Hsp70) member 4 like(HSPA4L)	Homo sapiens				GO:0006457~protein folding,GO:0006986~response to unfolded protein,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005524~ATP binding,	IPR013126:Heat shock protein 70 family,IPR018181:Heat shock protein 70, conserved site,	hsa04141:Protein processing in endoplasmic reticulum,				Acetylation,ATP-binding,Chaperone,Coiled coil,Complete proteome,Cytoplasm,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Stress response,	chain:Heat shock 70 kDa protein 4L,modified residue,sequence conflict,sequence variant,
HGF_HUMAN	hepatocyte growth factor(HGF)	Homo sapiens		h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,		GO:0000187~activation of MAPK activity,GO:0000902~cell morphogenesis,GO:0001837~epithelial to mesenchymal transition,GO:0001889~liver development,GO:0002576~platelet degranulation,GO:0006508~proteolysis,GO:0007067~mitotic nuclear division,GO:0008284~positive regulation of cell proliferation,GO:0010507~negative regulation of autophagy,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0030212~hyaluronan metabolic process,GO:0030335~positive regulation of cell migration,GO:0031100~organ regeneration,GO:0031643~positive regulation of myelination,GO:0032715~negative regulation of interleukin-6 production,GO:0032733~positive regulation of interleukin-10 production,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045669~positive regulation of osteoblast differentiation,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048012~hepatocyte growth factor receptor signaling pathway,GO:0050728~negative regulation of inflammatory response,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050918~positive chemotaxis,GO:0051450~myoblast proliferation,GO:0060326~cell chemotaxis,GO:0060665~regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,GO:0070572~positive regulation of neuron projection regeneration,GO:0090201~negative regulation of release of cytochrome c from mitochondria,GO:1900744~regulation of p38MAPK cascade,GO:1901299~negative regulation of hydrogen peroxide-mediated programmed cell death,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902947~regulation of tau-protein kinase activity,GO:2000573~positive regulation of DNA biosynthetic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016020~membrane,GO:0031093~platelet alpha granule lumen,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0042056~chemoattractant activity,GO:0042802~identical protein binding,GO:0046982~protein heterodimerization activity,	IPR000001:Kringle,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR003609:Apple-like,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR013806:Kringle-like fold,IPR018056:Kringle, conserved site,IPR024174:Hepatocyte growth factor/macrophage stimulating protein 1,IPR027284:Hepatocyte growth factor,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa05144:Malaria,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05211:Renal cell carcinoma,hsa05218:Melanoma,	608265~Deafness, autosomal recessive 39,	PIRSF001152:hepatocyte growth factor/macrophage stimulating protein 1,PIRSF500183:hepatocyte growth factor [Parent=PIRSF001152],	SM00020:Tryp_SPc,SM00130:KR,SM00473:PAN_AP,	3D-structure,Alternative splicing,Complete proteome,Deafness,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor,Kringle,Non-syndromic deafness,Polymorphism,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Repeat,Serine protease homolog,Signal,	chain:Hepatocyte growth factor alpha chain,chain:Hepatocyte growth factor beta chain,disulfide bond,domain:Kringle 1,domain:Kringle 2,domain:Kringle 3,domain:Kringle 4,domain:PAN,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...) (complex),glycosylation site:O-linked (GalNAc...),helix,modified residue,mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
HXK2_HUMAN	hexokinase 2(HK2)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0001678~cellular glucose homeostasis,GO:0002931~response to ischemia,GO:0006096~glycolytic process,GO:0007595~lactation,GO:0008637~apoptotic mitochondrial changes,GO:0015758~glucose transport,GO:0035795~negative regulation of mitochondrial membrane permeability,GO:0046324~regulation of glucose import,GO:0046835~carbohydrate phosphorylation,GO:0051156~glucose 6-phosphate metabolic process,GO:0061621~canonical glycolysis,GO:0072655~establishment of protein localization to mitochondrion,GO:0072656~maintenance of protein location in mitochondrion,GO:1904925~positive regulation of mitophagy in response to mitochondrial depolarization,GO:2000378~negative regulation of reactive oxygen species metabolic process,	GO:0005623~cell,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0016020~membrane,	GO:0004340~glucokinase activity,GO:0004396~hexokinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005536~glucose binding,GO:0008865~fructokinase activity,GO:0019158~mannokinase activity,	IPR001312:Hexokinase,IPR019807:Hexokinase, conserved site,IPR022672:Hexokinase, N-terminal,IPR022673:Hexokinase, C-terminal,	hsa00010:Glycolysis / Gluconeogenesis,hsa00051:Fructose and mannose metabolism,hsa00052:Galactose metabolism,hsa00500:Starch and sucrose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa00524:Butirosin and neomycin biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04066:HIF-1 signaling pathway,hsa04910:Insulin signaling pathway,hsa04930:Type II diabetes mellitus,hsa04973:Carbohydrate digestion and absorption,hsa05230:Central carbon metabolism in cancer,				3D-structure,Acetylation,Allosteric enzyme,ATP-binding,Complete proteome,Glycolysis,Kinase,Membrane,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transferase,	binding site:ATP,binding site:ATP 1,binding site:ATP 2,binding site:Glucose-6-phosphate 1,binding site:Glucose-6-phosphate 2,binding site:Substrate 1,binding site:Substrate 2,chain:Hexokinase-2,helix,modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,region of interest:Catalytic,region of interest:Glucose-6-phosphate 1 binding,region of interest:Glucose-6-phosphate 2 binding,region of interest:Hydrophobic,region of interest:Regulatory,region of interest:Substrate 1 binding,region of interest:Substrate 2 binding,sequence conflict,sequence variant,strand,turn,
HMGA2_HUMAN	high mobility group AT-hook 2(HMGA2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001837~epithelial to mesenchymal transition,GO:0002062~chondrocyte differentiation,GO:0003131~mesodermal-endodermal cell signaling,GO:0006284~base-excision repair,GO:0006325~chromatin organization,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007067~mitotic nuclear division,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0008584~male gonad development,GO:0009615~response to virus,GO:0010564~regulation of cell cycle process,GO:0010628~positive regulation of gene expression,GO:0021846~cell proliferation in forebrain,GO:0021983~pituitary gland development,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030261~chromosome condensation,GO:0030325~adrenal gland development,GO:0031052~chromosome breakage,GO:0031507~heterochromatin assembly,GO:0033144~negative regulation of intracellular steroid hormone receptor signaling pathway,GO:0035019~somatic stem cell population maintenance,GO:0035978~histone H2A-S139 phosphorylation,GO:0035986~senescence-associated heterochromatin focus assembly,GO:0035987~endodermal cell differentiation,GO:0035988~chondrocyte proliferation,GO:0040008~regulation of growth,GO:0040018~positive regulation of multicellular organism growth,GO:0042769~DNA damage response, detection of DNA damage,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043392~negative regulation of DNA binding,GO:0043922~negative regulation by host of viral transcription,GO:0045444~fat cell differentiation,GO:0045869~negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046426~negative regulation of JAK-STAT cascade,GO:0048333~mesodermal cell differentiation,GO:0048712~negative regulation of astrocyte differentiation,GO:0048762~mesenchymal cell differentiation,GO:0048863~stem cell differentiation,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051301~cell division,GO:0060123~regulation of growth hormone secretion,GO:0060428~lung epithelium development,GO:0060441~epithelial tube branching involved in lung morphogenesis,GO:0060501~positive regulation of epithelial cell proliferation involved in lung morphogenesis,GO:0060613~fat pad development,GO:0071158~positive regulation of cell cycle arrest,GO:0090402~oncogene-induced cell senescence,GO:2000036~regulation of stem cell population maintenance,GO:2000648~positive regulation of stem cell proliferation,GO:2000679~positive regulation of transcription regulatory region DNA binding,GO:2000685~positive regulation of cellular response to X-ray,GO:2000774~positive regulation of cellular senescence,GO:2001022~positive regulation of response to DNA damage stimulus,GO:2001033~negative regulation of double-strand break repair via nonhomologous end joining,GO:2001038~regulation of cellular response to drug,	GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0032993~protein-DNA complex,GO:0035985~senescence-associated heterochromatin focus,GO:0071141~SMAD protein complex,	GO:0000975~regulatory region DNA binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0001047~core promoter binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003680~AT DNA binding,GO:0003906~DNA-(apurinic or apyrimidinic site) lyase activity,GO:0004677~DNA-dependent protein kinase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008301~DNA binding, bending,GO:0031492~nucleosomal DNA binding,GO:0035497~cAMP response element binding,GO:0035500~MH2 domain binding,GO:0035501~MH1 domain binding,GO:0046332~SMAD binding,GO:0051575~5'-deoxyribose-5-phosphate lyase activity,GO:0070742~C2H2 zinc finger domain binding,	IPR000116:High mobility group, HMG-I/HMG-Y,IPR000637:HMG-I/HMG-Y, DNA-binding, conserved site,IPR017956:AT hook, DNA-binding motif,	hsa05202:Transcriptional misregulation in cancer,hsa05206:MicroRNAs in cancer,	150699~Leiomyoma, uterine, somatic,		SM00384:AT_hook,	Acetylation,Alternative splicing,Cell cycle,Cell division,Chromosomal rearrangement,Complete proteome,Direct protein sequencing,DNA condensation,DNA-binding,Growth regulation,Mitosis,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:High mobility group protein HMGI-C,DNA-binding region:A.T hook 1,DNA-binding region:A.T hook 2,DNA-binding region:A.T hook 3,modified residue,region of interest:Interaction with E4F1,
DHI1_HUMAN	hydroxysteroid 11-beta dehydrogenase 1(HSD11B1)	Homo sapiens		h_vobesityPathway:Visceral Fat Deposits and the Metabolic Syndrome,	Cell envelope biogenesis, outer membrane,	GO:0006704~glucocorticoid biosynthetic process,GO:0030324~lung development,GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003845~11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,GO:0016491~oxidoreductase activity,GO:0070524~11-beta-hydroxysteroid dehydrogenase (NADP+) activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	hsa00140:Steroid hormone biosynthesis,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,	614662~Cortisone reductase deficiency 2,			3D-structure,Complete proteome,Endoplasmic reticulum,Glycoprotein,Lipid metabolism,Membrane,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Steroid metabolism,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:Substrate,chain:Corticosteroid 11-beta-dehydrogenase isozyme 1,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,nucleotide phosphate-binding region:NADP,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
IDS_HUMAN	iduronate 2-sulfatase(IDS)	Homo sapiens			Inorganic ion transport and metabolism,	GO:0006027~glycosaminoglycan catabolic process,GO:0008152~metabolic process,GO:0030207~chondroitin sulfate catabolic process,	GO:0043202~lysosomal lumen,	GO:0004423~iduronate-2-sulfatase activity,GO:0008484~sulfuric ester hydrolase activity,GO:0046872~metal ion binding,	IPR000917:Sulfatase,IPR017849:Alkaline phosphatase-like, alpha/beta/alpha,IPR017850:Alkaline-phosphatase-like, core domain,IPR024607:Sulfatase, conserved site,	hsa00531:Glycosaminoglycan degradation,hsa01100:Metabolic pathways,hsa04142:Lysosome,	309900~Mucopolysaccharidosis II,			Alternative splicing,Calcium,Complete proteome,Direct protein sequencing,Disease mutation,Glycoprotein,Hydrolase,Lysosome,Metal-binding,Mucopolysaccharidosis,Proteomics identification,Reference proteome,Signal,Zymogen,	chain:Iduronate 2-sulfatase 14 kDa chain,chain:Iduronate 2-sulfatase 42 kDa chain,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Calcium,metal ion-binding site:Calcium; via 3-oxoalanine,modified residue,sequence variant,signal peptide,splice variant,
INHBA_HUMAN	inhibin beta A subunit(INHBA)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0001541~ovarian follicle development,GO:0001942~hair follicle development,GO:0002244~hematopoietic progenitor cell differentiation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006952~defense response,GO:0007050~cell cycle arrest,GO:0007166~cell surface receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007399~nervous system development,GO:0008285~negative regulation of cell proliferation,GO:0008584~male gonad development,GO:0010628~positive regulation of gene expression,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0021773~striatal medium spiny neuron differentiation,GO:0030154~cell differentiation,GO:0030218~erythrocyte differentiation,GO:0030308~negative regulation of cell growth,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032924~activin receptor signaling pathway,GO:0035987~endodermal cell differentiation,GO:0040007~growth,GO:0042326~negative regulation of phosphorylation,GO:0042476~odontogenesis,GO:0042493~response to drug,GO:0042541~hemoglobin biosynthetic process,GO:0042701~progesterone secretion,GO:0043408~regulation of MAPK cascade,GO:0045077~negative regulation of interferon-gamma biosynthetic process,GO:0045578~negative regulation of B cell differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045650~negative regulation of macrophage differentiation,GO:0045786~negative regulation of cell cycle,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046880~regulation of follicle-stimulating hormone secretion,GO:0046881~positive regulation of follicle-stimulating hormone secretion,GO:0046882~negative regulation of follicle-stimulating hormone secretion,GO:0048333~mesodermal cell differentiation,GO:0048468~cell development,GO:0051799~negative regulation of hair follicle development,GO:0060021~palate development,GO:0060279~positive regulation of ovulation,GO:0060395~SMAD protein signal transduction,GO:0061029~eyelid development in camera-type eye,GO:0071372~cellular response to follicle-stimulating hormone stimulus,GO:0071397~cellular response to cholesterol,GO:0097154~GABAergic neuron differentiation,GO:0097191~extrinsic apoptotic signaling pathway,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005576~extracellular region,GO:0043509~activin A complex,GO:0043512~inhibin A complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005179~hormone activity,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0017046~peptide hormone binding,GO:0034711~inhibin binding,GO:0042802~identical protein binding,GO:0046982~protein heterodimerization activity,GO:0070699~type II activin receptor binding,	IPR000491:Inhibin, beta A subunit,IPR001111:Transforming growth factor-beta, N-terminal,IPR001839:Transforming growth factor-beta, C-terminal,IPR015615:Transforming growth factor-beta-related,IPR017948:Transforming growth factor beta, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00204:TGFB,	3D-structure,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Glycoprotein,Growth factor,Hormone,Polymorphism,Reference proteome,Secreted,Signal,	chain:Inhibin beta A chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,strand,turn,
IP3KA_HUMAN	inositol-trisphosphate 3-kinase A(ITPKA)	Homo sapiens				GO:0006020~inositol metabolic process,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0030036~actin cytoskeleton organization,GO:0043647~inositol phosphate metabolic process,GO:0048167~regulation of synaptic plasticity,GO:0061003~positive regulation of dendritic spine morphogenesis,GO:0097062~dendritic spine maintenance,	GO:0005829~cytosol,GO:0043197~dendritic spine,	GO:0004683~calmodulin-dependent protein kinase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008440~inositol-1,4,5-trisphosphate 3-kinase activity,GO:0048365~Rac GTPase binding,	IPR005522:Inositol polyphosphate kinase,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04020:Calcium signaling pathway,hsa04070:Phosphatidylinositol signaling system,				3D-structure,ATP-binding,Calmodulin-binding,Complete proteome,Kinase,Methylation,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,	binding site:ATP,binding site:Substrate,chain:Inositol-trisphosphate 3-kinase A,helix,nucleotide phosphate-binding region:ATP,region of interest:Calmodulin-binding,region of interest:Substrate binding,sequence conflict,strand,turn,
IBP5_HUMAN	insulin like growth factor binding protein 5(IGFBP5)	Homo sapiens		h_ghrelinPathway:Ghrelin: Regulation of Food Intake and Energy Homeostasis,		GO:0001558~regulation of cell growth,GO:0001649~osteoblast differentiation,GO:0006006~glucose metabolic process,GO:0007165~signal transduction,GO:0007565~female pregnancy,GO:0007568~aging,GO:0010906~regulation of glucose metabolic process,GO:0014912~negative regulation of smooth muscle cell migration,GO:0017148~negative regulation of translation,GO:0030336~negative regulation of cell migration,GO:0031069~hair follicle morphogenesis,GO:0035556~intracellular signal transduction,GO:0042593~glucose homeostasis,GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway,GO:0043569~negative regulation of insulin-like growth factor receptor signaling pathway,GO:0044267~cellular protein metabolic process,GO:0044342~type B pancreatic cell proliferation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045926~negative regulation of growth,GO:0048286~lung alveolus development,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0051146~striated muscle cell differentiation,GO:0051897~positive regulation of protein kinase B signaling,GO:0060056~mammary gland involution,GO:0060416~response to growth hormone,GO:0071320~cellular response to cAMP,GO:0071407~cellular response to organic cyclic compound,GO:1901862~negative regulation of muscle tissue development,GO:1904205~negative regulation of skeletal muscle hypertrophy,	GO:0005576~extracellular region,GO:0005622~intracellular,GO:0016942~insulin-like growth factor binding protein complex,GO:0042567~insulin-like growth factor ternary complex,	GO:0001968~fibronectin binding,GO:0005515~protein binding,GO:0031994~insulin-like growth factor I binding,GO:0031995~insulin-like growth factor II binding,	IPR000716:Thyroglobulin type-1,IPR000867:Insulin-like growth factor-binding protein, IGFBP,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR009168:Insulin-like growth factor binding protein,IPR012213:Insulin-like growth factor binding protein 5,IPR017891:Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site,IPR022321:Insulin-like growth factor-binding protein family 1-6, chordata,				SM00121:IB,SM00211:TY,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Insulin-like growth factor-binding protein 5,disulfide bond,domain:IGFBP N-terminal,domain:Thyroglobulin type-1,glycosylation site:O-linked (HexNAc...),helix,sequence variant,signal peptide,strand,
ITA1_HUMAN	integrin subunit alpha 1(ITGA1)	Homo sapiens				GO:0000187~activation of MAPK activity,GO:0006936~muscle contraction,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0030198~extracellular matrix organization,GO:0030593~neutrophil chemotaxis,GO:0032516~positive regulation of phosphoprotein phosphatase activity,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0042311~vasodilation,GO:0043525~positive regulation of neuron apoptotic process,GO:0045123~cellular extravasation,GO:0048812~neuron projection morphogenesis,	GO:0001669~acrosomal vesicle,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0008305~integrin complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0034665~integrin alpha1-beta1 complex,GO:0043005~neuron projection,GO:0043204~perikaryon,GO:0045121~membrane raft,GO:0045178~basal part of cell,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0019903~protein phosphatase binding,GO:0046872~metal ion binding,GO:0098639~collagen binding involved in cell-matrix adhesion,	IPR000413:Integrin alpha chain,IPR002035:von Willebrand factor, type A,IPR013517:FG-GAP repeat,IPR013519:Integrin alpha beta-propellor,IPR013649:Integrin alpha-2,IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04640:Hematopoietic cell lineage,hsa04810:Regulation of actin cytoskeleton,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,			SM00191:Int_alpha,SM00327:VWA,	3D-structure,Calcium,Cell adhesion,Complete proteome,Disulfide bond,Glycoprotein,Integrin,Magnesium,Membrane,Metal-binding,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Integrin alpha-1,disulfide bond,domain:VWFA,glycosylation site:N-linked (GlcNAc...),helix,repeat:FG-GAP 1,repeat:FG-GAP 2,repeat:FG-GAP 3,repeat:FG-GAP 4,repeat:FG-GAP 5,repeat:FG-GAP 6,repeat:FG-GAP 7,sequence conflict,sequence variant,short sequence motif:GFFKR motif,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ICAM1_HUMAN	intercellular adhesion molecule 1(ICAM1)	Homo sapiens	125.T_Cells_CNS-APCs,18.Cytokine_astocytes,55.Allergen_recognition_by_Th2_or_Th0_cell,58.(CD40L)_immnosurveillance,60.IL-15_rheumatoid-arthritis_synovitis,8.MonocytesIFNF_IL4,81.Structure_of_Caps_and_SMACs,96.Immune_injury_MS-lesions_genetic_environ,	h_blymphocytePathway:B Lymphocyte Cell Surface Molecules,h_ctlPathway:CTL mediated immune response against target cells ,h_granulocytesPathway:Adhesion and Diapedesis of Granulocytes,h_LairPathway:Cells and Molecules involved in local acute inflammatory response,h_lymPathway:Adhesion and Diapedesis of Lymphocytes,h_lymphocytePathway:Adhesion Molecules on Lymphocyte,h_monocytePathway:Monocyte and its Surface Molecules,h_neutrophilPathway:Neutrophil and Its Surface Molecules,h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules,h_thelperPathway:T Helper Cell Surface Molecules,		GO:0001541~ovarian follicle development,GO:0001910~regulation of leukocyte mediated cytotoxicity,GO:0001975~response to amphetamine,GO:0002291~T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,GO:0002438~acute inflammatory response to antigenic stimulus,GO:0002457~T cell antigen processing and presentation,GO:0002693~positive regulation of cellular extravasation,GO:0007155~cell adhesion,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007159~leukocyte cell-cell adhesion,GO:0007569~cell aging,GO:0007605~sensory perception of sound,GO:0008360~regulation of cell shape,GO:0010212~response to ionizing radiation,GO:0010477~response to sulfur dioxide,GO:0014070~response to organic cyclic compound,GO:0016337~single organismal cell-cell adhesion,GO:0022614~membrane to membrane docking,GO:0030155~regulation of cell adhesion,GO:0030198~extracellular matrix organization,GO:0030838~positive regulation of actin filament polymerization,GO:0031669~cellular response to nutrient levels,GO:0033627~cell adhesion mediated by integrin,GO:0034698~response to gonadotropin,GO:0042493~response to drug,GO:0043200~response to amino acid,GO:0043547~positive regulation of GTPase activity,GO:0044406~adhesion of symbiont to host,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045471~response to ethanol,GO:0045907~positive regulation of vasoconstriction,GO:0046688~response to copper ion,GO:0046718~viral entry into host cell,GO:0046813~receptor-mediated virion attachment to host cell,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050776~regulation of immune response,GO:0050900~leukocyte migration,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051926~negative regulation of calcium ion transport,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0061028~establishment of endothelial barrier,GO:0070234~positive regulation of T cell apoptotic process,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071222~cellular response to lipopolysaccharide,GO:0071312~cellular response to alkaloid,GO:0071333~cellular response to glucose stimulus,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071456~cellular response to hypoxia,GO:0097368~establishment of Sertoli cell barrier,GO:1900027~regulation of ruffle assembly,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000352~negative regulation of endothelial cell apoptotic process,	GO:0001772~immunological synapse,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005178~integrin binding,GO:0005515~protein binding,	IPR003599:Immunoglobulin subtype,IPR003987:Intercellular adhesion molecule/vascular cell adhesion molecule, N-terminal,IPR003988:Intercellular adhesion molecule,IPR007110:Immunoglobulin-like domain,IPR013768:Intercellular adhesion molecule, N-terminal,IPR013783:Immunoglobulin-like fold,	hsa04064:NF-kappa B signaling pathway,hsa04514:Cell adhesion molecules (CAMs),hsa04650:Natural killer cell mediated cytotoxicity,hsa04668:TNF signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa05143:African trypanosomiasis,hsa05144:Malaria,hsa05150:Staphylococcus aureus infection,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05323:Rheumatoid arthritis,hsa05416:Viral myocarditis,	611162~Malaria, cerebral, susceptibility to,		SM00409:IG,	3D-structure,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Intercellular adhesion molecule 1,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,short sequence motif:Cell attachment site; atypical,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
IL1A_HUMAN	interleukin 1 alpha(IL1A)	Homo sapiens	110.CRHandLC-NA,114.Genomic_reformatting_Brain_Ischemia,125.T_Cells_CNS-APCs,19.Cytokine_microglia,22.Cytokine-chemokine_CNS,56.Macrophage_regulation_of_CD4+T_cells,58.(CD40L)_immnosurveillance,88.Alternatively_Activated_APC,	h_cytokinePathway:Cytokine Network,h_erythPathway:Erythrocyte Differentiation Pathway,h_granulocytesPathway:Adhesion and Diapedesis of Granulocytes,h_hsp27Pathway:Stress Induction of HSP Regulation,h_il10Pathway:IL-10 Anti-inflammatory Signaling Pathway,h_il1rPathway:Signal transduction through IL1R,h_inflamPathway:Cytokines and Inflammatory Response,h_LairPathway:Cells and Molecules involved in local acute inflammatory response,h_lymPathway:Adhesion and Diapedesis of Lymphocytes,h_nfkbPathway:NF-kB Signaling Pathway,		GO:0001660~fever generation,GO:0002248~connective tissue replacement involved in inflammatory response wound healing,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010628~positive regulation of gene expression,GO:0019221~cytokine-mediated signaling pathway,GO:0032755~positive regulation of interleukin-6 production,GO:0034605~cellular response to heat,GO:0035234~ectopic germ cell programmed cell death,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045086~positive regulation of interleukin-2 biosynthetic process,GO:0045766~positive regulation of angiogenesis,GO:0045840~positive regulation of mitotic nuclear division,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046330~positive regulation of JNK cascade,GO:0046688~response to copper ion,GO:0050714~positive regulation of protein secretion,GO:0050715~positive regulation of cytokine secretion,GO:0051781~positive regulation of cell division,GO:0070498~interleukin-1-mediated signaling pathway,GO:0071639~positive regulation of monocyte chemotactic protein-1 production,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:2000391~positive regulation of neutrophil extravasation,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005829~cytosol,	GO:0005125~cytokine activity,GO:0005149~interleukin-1 receptor binding,GO:0005507~copper ion binding,GO:0005515~protein binding,	IPR000975:Interleukin-1,IPR003294:Interleukin-1, alpha/beta,IPR003295:Interleukin-1, alpha IL1A,IPR003502:Interleukin-1 propeptide,IPR008996:Cytokine, IL-1-like,IPR020877:Interleukin-1 conserved site,	hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04380:Osteoclast differentiation,hsa04640:Hematopoietic cell lineage,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04940:Type I diabetes mellitus,hsa05020:Prion diseases,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05140:Leishmaniasis,hsa05152:Tuberculosis,hsa05162:Measles,hsa05164:Influenza A,hsa05321:Inflammatory bowel disease (IBD),hsa05323:Rheumatoid arthritis,hsa05332:Graft-versus-host disease,				3D-structure,Complete proteome,Cytokine,Direct protein sequencing,Glycoprotein,Inflammatory response,Lipoprotein,Mitogen,Myristate,Phosphoprotein,Polymorphism,Pyrogen,Reference proteome,Secreted,	chain:Interleukin-1 alpha,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:N6-myristoyl lysine,sequence variant,strand,turn,
IL1B_HUMAN	interleukin 1 beta(IL1B)	Homo sapiens		h_il1rPathway:Signal transduction through IL1R,h_il5Pathway:IL 5 Signaling Pathway,h_mspPathway:Msp/Ron Receptor Signaling Pathway,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,		GO:0000165~MAPK cascade,GO:0000187~activation of MAPK activity,GO:0001660~fever generation,GO:0001934~positive regulation of protein phosphorylation,GO:0002711~positive regulation of T cell mediated immunity,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0007566~embryo implantation,GO:0008285~negative regulation of cell proliferation,GO:0009743~response to carbohydrate,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010628~positive regulation of gene expression,GO:0010829~negative regulation of glucose transport,GO:0014805~smooth muscle adaptation,GO:0019221~cytokine-mediated signaling pathway,GO:0030213~hyaluronan biosynthetic process,GO:0030593~neutrophil chemotaxis,GO:0030730~sequestering of triglyceride,GO:0030949~positive regulation of vascular endothelial growth factor receptor signaling pathway,GO:0031622~positive regulation of fever generation,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032308~positive regulation of prostaglandin secretion,GO:0032611~interleukin-1 beta production,GO:0032725~positive regulation of granulocyte macrophage colony-stimulating factor production,GO:0032729~positive regulation of interferon-gamma production,GO:0032755~positive regulation of interleukin-6 production,GO:0032757~positive regulation of interleukin-8 production,GO:0033129~positive regulation of histone phosphorylation,GO:0033198~response to ATP,GO:0034116~positive regulation of heterotypic cell-cell adhesion,GO:0035066~positive regulation of histone acetylation,GO:0035234~ectopic germ cell programmed cell death,GO:0035505~positive regulation of myosin light chain kinase activity,GO:0035690~cellular response to drug,GO:0042102~positive regulation of T cell proliferation,GO:0042346~positive regulation of NF-kappaB import into nucleus,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043407~negative regulation of MAP kinase activity,GO:0043491~protein kinase B signaling,GO:0045080~positive regulation of chemokine biosynthetic process,GO:0045086~positive regulation of interleukin-2 biosynthetic process,GO:0045410~positive regulation of interleukin-6 biosynthetic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045766~positive regulation of angiogenesis,GO:0045833~negative regulation of lipid metabolic process,GO:0045840~positive regulation of mitotic nuclear division,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046330~positive regulation of JNK cascade,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0046827~positive regulation of protein export from nucleus,GO:0050766~positive regulation of phagocytosis,GO:0050796~regulation of insulin secretion,GO:0050995~negative regulation of lipid catabolic process,GO:0050996~positive regulation of lipid catabolic process,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051044~positive regulation of membrane protein ectodomain proteolysis,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051781~positive regulation of cell division,GO:0060355~positive regulation of cell adhesion molecule production,GO:0060559~positive regulation of calcidiol 1-monooxygenase activity,GO:0070164~negative regulation of adiponectin secretion,GO:0070487~monocyte aggregation,GO:0071260~cellular response to mechanical stimulus,GO:0071310~cellular response to organic substance,GO:0071407~cellular response to organic cyclic compound,GO:0071639~positive regulation of monocyte chemotactic protein-1 production,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1903140~regulation of establishment of endothelial barrier,GO:2000778~positive regulation of interleukin-6 secretion,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005776~autophagosome,GO:0005829~cytosol,GO:0030141~secretory granule,GO:0070062~extracellular exosome,	GO:0005125~cytokine activity,GO:0005149~interleukin-1 receptor binding,GO:0019904~protein domain specific binding,	IPR000975:Interleukin-1,IPR003294:Interleukin-1, alpha/beta,IPR003296:Interleukin-1, beta IL1B,IPR003502:Interleukin-1 propeptide,IPR008996:Cytokine, IL-1-like,IPR020877:Interleukin-1 conserved site,	hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04064:NF-kappa B signaling pathway,hsa04380:Osteoclast differentiation,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04640:Hematopoietic cell lineage,hsa04668:TNF signaling pathway,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04940:Type I diabetes mellitus,hsa05010:Alzheimer's disease,hsa05020:Prion diseases,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05134:Legionellosis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05143:African trypanosomiasis,hsa05144:Malaria,hsa05146:Amoebiasis,hsa05152:Tuberculosis,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05321:Inflammatory bowel disease (IBD),hsa05323:Rheumatoid arthritis,hsa05332:Graft-versus-host disease,	137215~Gastric cancer risk after H. pylori infection,			3D-structure,Complete proteome,Cytokine,Cytoplasm,Cytoplasmic vesicle,Direct protein sequencing,Inflammatory response,Lysosome,Mitogen,Polymorphism,Proteomics identification,Pyrogen,Reference proteome,Secreted,	chain:Interleukin-1 beta,helix,sequence conflict,site:Involved in receptor binding,strand,turn,
IL1AP_HUMAN	interleukin 1 receptor accessory protein(IL1RAP)	Homo sapiens		h_il1rPathway:Signal transduction through IL1R,		GO:0006461~protein complex assembly,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0032736~positive regulation of interleukin-13 production,GO:0032754~positive regulation of interleukin-5 production,GO:0038172~interleukin-33-mediated signaling pathway,GO:0042094~interleukin-2 biosynthetic process,GO:0045087~innate immune response,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051965~positive regulation of synapse assembly,GO:0072602~interleukin-4 secretion,GO:1900006~positive regulation of dendrite development,GO:2000778~positive regulation of interleukin-6 secretion,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0002114~interleukin-33 receptor activity,GO:0004871~signal transducer activity,GO:0004908~interleukin-1 receptor activity,GO:1990782~protein tyrosine kinase binding,	IPR000157:Toll/interleukin-1 receptor homology (TIR) domain,IPR003599:Immunoglobulin subtype,IPR004074:Interleukin-1 receptor, type I/II,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015621:Interleukin-1 receptor family,	hsa04060:Cytokine-cytokine receptor interaction,hsa04750:Inflammatory mediator regulation of TRP channels,			SM00255:TIR,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Inflammatory response,Innate immunity,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-1 receptor accessory protein,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:TIR,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IL18R_HUMAN	interleukin 18 receptor 1(IL18R1)	Homo sapiens		h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_th1th2Pathway:Th1/Th2 Differentiation,		GO:0006955~immune response,GO:0007165~signal transduction,GO:0030101~natural killer cell activation,GO:0032729~positive regulation of interferon-gamma production,GO:0035655~interleukin-18-mediated signaling pathway,GO:0042346~positive regulation of NF-kappaB import into nucleus,GO:0045063~T-helper 1 cell differentiation,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0004908~interleukin-1 receptor activity,GO:0005515~protein binding,GO:0042008~interleukin-18 receptor activity,	IPR000157:Toll/interleukin-1 receptor homology (TIR) domain,IPR003599:Immunoglobulin subtype,IPR004074:Interleukin-1 receptor, type I/II,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015621:Interleukin-1 receptor family,	hsa04060:Cytokine-cytokine receptor interaction,hsa04668:TNF signaling pathway,hsa05321:Inflammatory bowel disease (IBD),			SM00255:TIR,SM00409:IG,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-18 receptor 1,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:TIR,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
KYNU_HUMAN	kynureninase(KYNU)	Homo sapiens				GO:0006569~tryptophan catabolic process,GO:0009435~NAD biosynthetic process,GO:0019441~tryptophan catabolic process to kynurenine,GO:0019442~tryptophan catabolic process to acetyl-CoA,GO:0019805~quinolinate biosynthetic process,GO:0034341~response to interferon-gamma,GO:0034354~'de novo' NAD biosynthetic process from tryptophan,GO:0034516~response to vitamin B6,GO:0043420~anthranilate metabolic process,GO:0097053~L-kynurenine catabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0030170~pyridoxal phosphate binding,GO:0030429~kynureninase activity,GO:0042803~protein homodimerization activity,	IPR000192:Aminotransferase, class V/Cysteine desulfurase,IPR010111:Kynureninase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,	hsa00380:Tryptophan metabolism,hsa01100:Metabolic pathways,	236800~Hydroxykynureninuria,	PIRSF038800:kynureninase,		3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Hydrolase,Polymorphism,Proteomics identification,Pyridine nucleotide biosynthesis,Pyridoxal phosphate,Reference proteome,	binding site:Pyridoxal phosphate,binding site:Pyridoxal phosphate; via amide nitrogen,chain:Kynureninase,helix,modified residue,region of interest:Pyridoxal phosphate binding,sequence variant,strand,turn,
LACC1_HUMAN	laccase domain containing 1(LACC1)	Homo sapiens			Secondary metabolites biosynthesis, transport and catabolism,		GO:0005777~peroxisome,	GO:0005507~copper ion binding,GO:0005515~protein binding,	IPR003730:Multi-copper polyphenol oxidoreductase, laccase,IPR011324:Cytotoxic necrotizing factor-like, catalytic,					Complete proteome,Peroxisome,Polymorphism,Proteomics identification,Reference proteome,	chain:UPF0124 protein C13orf31,sequence variant,
LRC17_HUMAN	leucine rich repeat containing 17(LRRC17)	Homo sapiens	92.Ancient_Host_Defense_Pathways,			GO:0001503~ossification,GO:0001649~osteoblast differentiation,GO:0033687~osteoblast proliferation,GO:0045671~negative regulation of osteoclast differentiation,GO:0048539~bone marrow development,	GO:0005615~extracellular space,		IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00082:LRRCT,SM00369:LRR_TYP,	Alternative splicing,Complete proteome,Leucine-rich repeat,Osteogenesis,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Leucine-rich repeat-containing protein 17,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,sequence conflict,sequence variant,signal peptide,splice variant,
LRC8C_HUMAN	leucine rich repeat containing 8 family member C(LRRC8C)	Homo sapiens			Function unknown,	GO:0044070~regulation of anion transport,GO:0045444~fat cell differentiation,GO:0098656~anion transmembrane transport,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005225~volume-sensitive anion channel activity,GO:0005515~protein binding,	IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR021040:Leucine-rich repeat-containing protein 8, N-terminal,IPR026906:Leucine rich repeat 5,				SM00369:LRR_TYP,	Acetylation,Cell membrane,Complete proteome,Endoplasmic reticulum,Glycoprotein,Ion channel,Ion transport,Leucine-rich repeat,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Leucine-rich repeat-containing protein 8C,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,transmembrane region,
LRCH2_HUMAN	leucine rich repeats and calponin homology domain containing 2(LRCH2)	Homo sapiens			Function unknown,				IPR001611:Leucine-rich repeat,IPR001715:Calponin homology domain,IPR003591:Leucine-rich repeat, typical subtype,				SM00033:CH,SM00369:LRR_TYP,	Alternative splicing,Coiled coil,Complete proteome,Leucine-rich repeat,Reference proteome,Repeat,	chain:Leucine-rich repeat and calponin homology domain-containing protein 2,compositionally biased region:Gly-rich,domain:CH,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,
MMP1_HUMAN	matrix metallopeptidase 1(MMP1)	Homo sapiens				GO:0006508~proteolysis,GO:0016032~viral process,GO:0022617~extracellular matrix disassembly,GO:0030574~collagen catabolic process,GO:0032461~positive regulation of protein oligomerization,GO:0044267~cellular protein metabolic process,GO:0050900~leukocyte migration,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0031012~extracellular matrix,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0008270~zinc ion binding,	IPR000585:Hemopexin-like domain,IPR001818:Peptidase M10, metallopeptidase,IPR002477:Peptidoglycan binding-like,IPR006026:Peptidase, metallopeptidase,IPR016293:Peptidase M10A, metazoans,IPR018486:Hemopexin, conserved site,IPR018487:Hemopexin-like repeats,IPR021158:Peptidase M10A, cysteine switch, zinc binding site,IPR021190:Peptidase M10A,IPR024079:Metallopeptidase, catalytic domain,	hsa03320:PPAR signaling pathway,hsa05200:Pathways in cancer,hsa05219:Bladder cancer,hsa05323:Rheumatoid arthritis,	226600~Epidermolysis bullosa dystrophica, autosomal recessive, modifier of,606963~COPD, rate of decline of lung function in,	PIRSF001191:matrix metalloproteinase, stromelysin type,	SM00120:HX,SM00235:ZnMc,	3D-structure,Autocatalytic cleavage,Calcium,Collagen,Collagen degradation,Complete proteome,Direct protein sequencing,Disulfide bond,Extracellular matrix,Glycoprotein,Host-virus interaction,Hydrolase,Metal-binding,Metalloprotease,Phosphoprotein,Polymorphism,Protease,Reference proteome,Repeat,Secreted,Signal,Zinc,Zymogen,	chain:22 kDa interstitial collagenase,chain:27 kDa interstitial collagenase,chain:Interstitial collagenase,disulfide bond,domain:Hemopexin-like 1,domain:Hemopexin-like 2,domain:Hemopexin-like 3,domain:Hemopexin-like 4,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Calcium 3,metal ion-binding site:Calcium 3; via carbonyl oxygen,metal ion-binding site:Calcium 4; via carbonyl oxygen,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2; catalytic,metal ion-binding site:Zinc 2; in inhibited form,propeptide:Activation peptide,region of interest:Metalloprotease,sequence conflict,sequence variant,short sequence motif:Cysteine switch,signal peptide,site:Cleavage; by autolysis,strand,turn,
MMP3_HUMAN	matrix metallopeptidase 3(MMP3)	Homo sapiens				GO:0006508~proteolysis,GO:0010727~negative regulation of hydrogen peroxide metabolic process,GO:0022617~extracellular matrix disassembly,GO:0030574~collagen catabolic process,GO:0032461~positive regulation of protein oligomerization,GO:0071732~cellular response to nitric oxide,GO:1903209~positive regulation of oxidative stress-induced cell death,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR000585:Hemopexin-like domain,IPR001818:Peptidase M10, metallopeptidase,IPR002477:Peptidoglycan binding-like,IPR006026:Peptidase, metallopeptidase,IPR016293:Peptidase M10A, metazoans,IPR018486:Hemopexin, conserved site,IPR018487:Hemopexin-like repeats,IPR021158:Peptidase M10A, cysteine switch, zinc binding site,IPR021190:Peptidase M10A,IPR024079:Metallopeptidase, catalytic domain,	hsa04668:TNF signaling pathway,hsa05202:Transcriptional misregulation in cancer,hsa05323:Rheumatoid arthritis,	614466~Coronary heart disease, susceptibility to, 6,	PIRSF001191:matrix metalloproteinase, stromelysin type,	SM00120:HX,SM00235:ZnMc,	3D-structure,Calcium,Collagen degradation,Complete proteome,Direct protein sequencing,Disulfide bond,Extracellular matrix,Glycoprotein,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Zinc,Zymogen,	chain:Stromelysin-1,disulfide bond,domain:Hemopexin-like 1,domain:Hemopexin-like 2,domain:Hemopexin-like 3,domain:Hemopexin-like 4,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Calcium 3,metal ion-binding site:Calcium 3; via carbonyl oxygen,metal ion-binding site:Calcium 4; via carbonyl oxygen,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2; catalytic,metal ion-binding site:Zinc 2; in inhibited form,propeptide:Activation peptide,sequence conflict,sequence variant,short sequence motif:Cysteine switch,signal peptide,strand,turn,
MT1L_HUMAN	metallothionein 1L (gene/pseudogene)(MT1L)	Homo sapiens				GO:0045926~negative regulation of growth,GO:0071294~cellular response to zinc ion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0008270~zinc ion binding,	IPR000006:Metallothionein, vertebrate,IPR003019:Metallothionein superfamily, eukaryotic,IPR017854:Metallothionein domain,IPR018064:Metallothionein, vertebrate, metal binding site,IPR023587:Metallothionein domain, vertebrate,					Acetylation,Cadmium,Complete proteome,Copper,Metal-binding,Metal-thiolate cluster,Phosphoprotein,Reference proteome,Zinc,	chain:Metallothionein-1E,metal ion-binding site:Divalent metal cation; cluster A,metal ion-binding site:Divalent metal cation; cluster B,modified residue,region of interest:Alpha,region of interest:Beta,
MT2_HUMAN	metallothionein 2A(MT2A)	Homo sapiens				GO:0006878~cellular copper ion homeostasis,GO:0010038~response to metal ion,GO:0035690~cellular response to drug,GO:0036016~cellular response to interleukin-3,GO:0036018~cellular response to erythropoietin,GO:0045926~negative regulation of growth,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0071294~cellular response to zinc ion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0008144~drug binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR000006:Metallothionein, vertebrate,IPR003019:Metallothionein superfamily, eukaryotic,IPR017854:Metallothionein domain,IPR018064:Metallothionein, vertebrate, metal binding site,IPR023587:Metallothionein domain, vertebrate,	hsa04978:Mineral absorption,				3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Metal-binding,Metal-thiolate cluster,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,	chain:Metallothionein-2,helix,metal ion-binding site:Divalent metal cation; cluster A,metal ion-binding site:Divalent metal cation; cluster B,modified residue,region of interest:Alpha,region of interest:Beta,sequence variant,strand,
MSPD2_HUMAN	motile sperm domain containing 2(MOSPD2)	Homo sapiens					GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR000535:Major sperm protein,IPR001251:CRAL-TRIO domain,IPR008962:PapD-like,IPR011074:CRAL/TRIO, N-terminal domain,				SM00516:SEC14,	Alternative splicing,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Motile sperm domain-containing protein 2,domain:CRAL-TRIO,domain:MSP,modified residue,sequence variant,splice variant,transmembrane region,
MYO1D_HUMAN	myosin ID(MYO1D)	Homo sapiens				GO:0010923~negative regulation of phosphatase activity,GO:0051641~cellular localization,GO:0061502~early endosome to recycling endosome transport,	GO:0005768~endosome,GO:0005790~smooth endoplasmic reticulum,GO:0005829~cytosol,GO:0005903~brush border,GO:0016323~basolateral plasma membrane,GO:0016459~myosin complex,GO:0030424~axon,GO:0030673~axolemma,GO:0031410~cytoplasmic vesicle,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043209~myelin sheath,GO:0044853~plasma membrane raft,GO:0070062~extracellular exosome,GO:0097440~apical dendrite,	GO:0000146~microfilament motor activity,GO:0003774~motor activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0019904~protein domain specific binding,GO:0030898~actin-dependent ATPase activity,GO:0048306~calcium-dependent protein binding,GO:0051015~actin filament binding,	IPR000048:IQ motif, EF-hand binding site,IPR001609:Myosin head, motor domain,IPR010926:Myosin tail 2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00015:IQ,SM00242:MYSc,	Acetylation,Actin-binding,ATP-binding,Calmodulin-binding,Complete proteome,Direct protein sequencing,Motor protein,Myosin,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Myosin-Id,domain:IQ 1,domain:IQ 2,domain:Myosin head-like,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,
NEST_HUMAN	nestin(NES)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0030844~positive regulation of intermediate filament depolymerization,GO:0031076~embryonic camera-type eye development,GO:0032091~negative regulation of protein binding,GO:0043086~negative regulation of catalytic activity,GO:0043524~negative regulation of neuron apoptotic process,GO:0048858~cell projection morphogenesis,GO:0072089~stem cell proliferation,GO:2000179~positive regulation of neural precursor cell proliferation,	GO:0005737~cytoplasm,GO:0005882~intermediate filament,GO:0031012~extracellular matrix,GO:0045111~intermediate filament cytoskeleton,	GO:0005198~structural molecule activity,GO:0019215~intermediate filament binding,	IPR001664:Intermediate filament protein,IPR018039:Intermediate filament protein, conserved site,				SM01391:SM01391,	Acetylation,Coiled coil,Complete proteome,Developmental protein,Intermediate filament,Isopeptide bond,Neurogenesis,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:Nestin,modified residue,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2A,region of interest:Coil 2B,region of interest:Head,region of interest:Linker 1,region of interest:Linker 12,region of interest:Linker 2,region of interest:Rod,region of interest:Tail,sequence conflict,sequence variant,
NAMPT_HUMAN	nicotinamide phosphoribosyltransferase(NAMPT)	Homo sapiens				GO:0006769~nicotinamide metabolic process,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0007565~female pregnancy,GO:0007623~circadian rhythm,GO:0008284~positive regulation of cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0009435~NAD biosynthetic process,GO:0014070~response to organic cyclic compound,GO:0032922~circadian regulation of gene expression,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:0060612~adipose tissue development,	GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030054~cell junction,GO:0070062~extracellular exosome,	GO:0004514~nicotinate-nucleotide diphosphorylase (carboxylating) activity,GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0008144~drug binding,GO:0042803~protein homodimerization activity,GO:0047280~nicotinamide phosphoribosyltransferase activity,	IPR002638:Quinolinate phosphoribosyl transferase, C-terminal,IPR007229:Nicotinate phosphoribosyltransferase-related,IPR016471:Nicotinamide phosphoribosyl transferase,	hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,		PIRSF005943:nicotinamide phosphoribosyl transferase,		3D-structure,Acetylation,Biological rhythms,Complete proteome,Cytokine,Cytoplasm,Glycosyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Pyridine nucleotide biosynthesis,Reference proteome,Secreted,Transferase,	binding site:Diphosphate,binding site:Nicotinamide ribonucleotide,binding site:Nicotinamide ribonucleotide; via amide nitrogen,chain:Nicotinamide phosphoribosyltransferase,helix,modified residue,mutagenesis site,region of interest:Nicotinamide ribonucleotide binding,sequence variant,strand,turn,
NFKB2_HUMAN	nuclear factor kappa B subunit 2(NFKB2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002268~follicular dendritic cell differentiation,GO:0002467~germinal center formation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007568~aging,GO:0030198~extracellular matrix organization,GO:0032481~positive regulation of type I interferon production,GO:0032496~response to lipopolysaccharide,GO:0034097~response to cytokine,GO:0038061~NIK/NF-kappaB signaling,GO:0045087~innate immune response,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0048536~spleen development,GO:0051092~positive regulation of NF-kappaB transcription factor activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0033257~Bcl3/NF-kappaB2 complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,	IPR000451:NF-kappa-B/Rel/Dorsal,IPR000488:Death domain,IPR002110:Ankyrin repeat,IPR002909:Cell surface receptor IPT/TIG,IPR008967:p53-like transcription factor, DNA-binding,IPR011029:Death-like domain,IPR011539:Rel homology domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR020683:Ankyrin repeat-containing domain,	hsa04010:MAPK signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04380:Osteoclast differentiation,hsa05134:Legionellosis,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,	615577~Immunodeficiency, common variable, 10,		SM00005:DEATH,SM00248:ANK,SM00429:IPT,	3D-structure,Activator,Alternative splicing,ANK repeat,Biological rhythms,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Nuclear factor NF-kappa-B p100 subunit,chain:Nuclear factor NF-kappa-B p52 subunit,compositionally biased region:Gly-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:Death,domain:RHD,helix,modified residue,mutagenesis site,region of interest:GRR,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,site:Breakpoint for translocation to form NFKB2-IGHA1 oncogene,site:Cleavage (when cotranslationally processed),splice variant,strand,turn,
NR4A2_HUMAN	nuclear receptor subfamily 4 group A member 2(NR4A2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001666~response to hypoxia,GO:0001764~neuron migration,GO:0001975~response to amphetamine,GO:0006351~transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0008344~adult locomotory behavior,GO:0009791~post-embryonic development,GO:0021952~central nervous system projection neuron axonogenesis,GO:0021986~habenula development,GO:0030522~intracellular receptor signaling pathway,GO:0031668~cellular response to extracellular stimulus,GO:0034599~cellular response to oxidative stress,GO:0042053~regulation of dopamine metabolic process,GO:0042416~dopamine biosynthetic process,GO:0042551~neuron maturation,GO:0043085~positive regulation of catalytic activity,GO:0043401~steroid hormone mediated signaling pathway,GO:0043524~negative regulation of neuron apoptotic process,GO:0043576~regulation of respiratory gaseous exchange,GO:0045444~fat cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051866~general adaptation syndrome,GO:0060070~canonical Wnt signaling pathway,GO:0071376~cellular response to corticotropin-releasing hormone stimulus,GO:0071542~dopaminergic neuron differentiation,GO:1904948~midbrain dopaminergic neuron differentiation,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008270~zinc ion binding,GO:0035259~glucocorticoid receptor binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046965~retinoid X receptor binding,GO:0046982~protein heterodimerization activity,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR003070:Orphan nuclear receptor,IPR003073:Orphan nuclear receptor, NURR type,IPR013088:Zinc finger, NHR/GATA-type,	hsa04925:Aldosterone synthesis and secretion,			SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Metal-binding,Nucleus,Proteomics identification,Receptor,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Nuclear receptor subfamily 4 group A member 2,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,DNA-binding region:Nuclear receptor,helix,modified residue,region of interest:Ligand-binding,sequence conflict,strand,turn,zinc finger region:NR C4-type,
E9PL11_HUMAN	nuclear transcription factor Y subunit gamma(NFYC)	Homo sapiens		h_tercPathway:Overview of telomerase RNA component gene hTerc Transcriptional Regulation,	Transcription,	GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006457~protein folding,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016602~CCAAT-binding factor complex,GO:0032993~protein-DNA complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR003958:Transcription factor CBF/NF-Y/archaeal histone,IPR009072:Histone-fold,IPR027170:Transcriptional activator NFYC/HAP5 subunit,	hsa04612:Antigen processing and presentation,hsa05152:Tuberculosis,				3D-structure,Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Nuclear transcription factor Y subunit gamma,helix,sequence conflict,sequence variant,splice variant,strand,turn,
NP1L6_HUMAN	nucleosome assembly protein 1 like 6(NAP1L6)	Homo sapiens				GO:0006334~nucleosome assembly,	GO:0005634~nucleus,		IPR002164:Nucleosome assembly protein (NAP),					Complete proteome,Reference proteome,
G8JLL2_HUMAN	palmitoyl-protein thioesterase 2(PPT2)	Homo sapiens				GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0098734~macromolecule depalmitoylation,	GO:0005764~lysosome,GO:0016021~integral component of membrane,GO:0043202~lysosomal lumen,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0008474~palmitoyl-(protein) hydrolase activity,GO:0016790~thiolester hydrolase activity,GO:0098599~palmitoyl hydrolase activity,	IPR000073:Alpha/beta hydrolase fold-1,IPR002472:Palmitoyl protein thioesterase,	hsa00062:Fatty acid elongation,hsa01100:Metabolic pathways,hsa01212:Fatty acid metabolism,hsa04142:Lysosome,				3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	active site:Nucleophile,chain:Lysosomal thioesterase PPT2,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
PAPP1_HUMAN	pappalysin 1(PAPPA)	Homo sapiens				GO:0006508~proteolysis,GO:0007565~female pregnancy,GO:0032354~response to follicle-stimulating hormone,GO:0044267~cellular protein metabolic process,GO:0051384~response to glucocorticoid,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR000436:Sushi/SCR/CCP,IPR000800:Notch domain,IPR006558:LamG-like jellyroll fold,IPR008754:Peptidase M43, pregnancy-associated plasma-A,IPR011936:Myxococcus cysteine-rich repeat,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR024079:Metallopeptidase, catalytic domain,				SM00004:NL,SM00032:CCP,SM00560:LamGL,	Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Repeat,Secreted,Signal,Sushi,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Pappalysin-1,chain:Protein PAPPAS,compositionally biased region:Arg-rich,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,region of interest:Metalloprotease,sequence conflict,sequence variant,signal peptide,transmembrane region,
PALM2_HUMAN	paralemmin 2(PALM2)	Homo sapiens				GO:0008360~regulation of cell shape,	GO:0005886~plasma membrane,GO:0016020~membrane,		IPR004965:Paralemmin,					Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Lipoprotein,Membrane,Methylation,Palmitate,Phosphoprotein,Prenylation,Reference proteome,	chain:A-kinase anchor protein 2,chain:Paralemmin-2,lipid moiety-binding region:S-farnesyl cysteine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,region of interest:PKA-RII subunit binding domain,sequence conflict,sequence variant,splice variant,
PARVB_HUMAN	parvin beta(PARVB)	Homo sapiens				GO:0007155~cell adhesion,GO:0030031~cell projection assembly,GO:0030032~lamellipodium assembly,GO:0031532~actin cytoskeleton reorganization,GO:0071963~establishment or maintenance of cell polarity regulating cell shape,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0030018~Z disc,GO:0030027~lamellipodium,	GO:0003779~actin binding,GO:0005515~protein binding,	IPR001715:Calponin homology domain,	hsa04510:Focal adhesion,			SM00033:CH,	3D-structure,Actin-binding,Alternative splicing,Cell adhesion,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Beta-parvin,domain:CH 1,domain:CH 2,modified residue,sequence conflict,sequence variant,
PLPL2_HUMAN	patatin like phospholipase domain containing 2(PNPLA2)	Homo sapiens				GO:0010891~negative regulation of sequestering of triglyceride,GO:0010898~positive regulation of triglyceride catabolic process,GO:0016042~lipid catabolic process,GO:0019433~triglyceride catabolic process,GO:0019915~lipid storage,GO:0034389~lipid particle organization,GO:0036155~acylglycerol acyl-chain remodeling,GO:0055088~lipid homeostasis,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005811~lipid particle,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004465~lipoprotein lipase activity,GO:0004806~triglyceride lipase activity,GO:0016411~acylglycerol O-acyltransferase activity,	IPR002641:Patatin/Phospholipase A2-related,IPR016035:Acyl transferase/acyl hydrolase/lysophospholipase,	hsa00561:Glycerolipid metabolism,hsa01100:Metabolic pathways,hsa04923:Regulation of lipolysis in adipocytes,	610717~Neutral lipid storage disease with myopathy,			Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Glycoprotein,Hydrolase,Lipid degradation,Lipid droplet,Lipid metabolism,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Patatin-like phospholipase domain- containing protein 2,domain:Patatin,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:GXSXG,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
PTX3_HUMAN	pentraxin 3(PTX3)	Homo sapiens				GO:0001878~response to yeast,GO:0006954~inflammatory response,GO:0008228~opsonization,GO:0044869~negative regulation by host of viral exo-alpha-sialidase activity,GO:0044871~negative regulation by host of viral glycoprotein metabolic process,GO:0045087~innate immune response,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0046597~negative regulation of viral entry into host cell,GO:0050766~positive regulation of phagocytosis,GO:1903016~negative regulation of exo-alpha-sialidase activity,GO:1903019~negative regulation of glycoprotein metabolic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0001849~complement component C1q binding,GO:0001872~(1->3)-beta-D-glucan binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0046790~virion binding,	IPR001759:Pentaxin,IPR006558:LamG-like jellyroll fold,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00159:PTX,SM00560:LamGL,	Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Polymorphism,Reference proteome,Secreted,Signal,	chain:Pentraxin-related protein PTX3,disulfide bond,domain:Pentaxin,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
E7EU35_HUMAN	phosphatidylinositol transfer protein, cytoplasmic 1(PITPNC1)	Homo sapiens				GO:0006810~transport,GO:0007165~signal transduction,GO:0015914~phospholipid transport,	GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008525~phosphatidylcholine transporter activity,GO:0008526~phosphatidylinositol transporter activity,GO:0035091~phosphatidylinositol binding,GO:0070300~phosphatidic acid binding,GO:1901611~phosphatidylglycerol binding,	IPR001666:Phosphatidylinositol transfer protein,IPR023393:START-like domain,					Alternative splicing,Complete proteome,Cytoplasm,Lipid transport,Lipid-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transport,	chain:Cytoplasmic phosphatidylinositol transfer protein 1,modified residue,sequence conflict,splice variant,
PREX1_HUMAN	phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1(PREX1)	Homo sapiens				GO:0006801~superoxide metabolic process,GO:0007186~G-protein coupled receptor signaling pathway,GO:0030041~actin filament polymerization,GO:0030217~T cell differentiation,GO:0030593~neutrophil chemotaxis,GO:0030833~regulation of actin filament polymerization,GO:0035023~regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0042119~neutrophil activation,GO:0043547~positive regulation of GTPase activity,GO:0050773~regulation of dendrite development,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030426~growth cone,GO:0043198~dendritic shaft,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0019899~enzyme binding,	IPR000219:Dbl homology (DH) domain,IPR000591:DEP domain,IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site,IPR001478:PDZ domain,IPR001849:Pleckstrin homology domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR011993:Pleckstrin homology-like domain,	hsa04062:Chemokine signaling pathway,			SM00049:DEP,SM00228:PDZ,SM00233:PH,SM00325:RhoGEF,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Phosphatidylinositol 3,4,5-trisphosphate- dependent Rac exchanger 1 protein,domain:DEP 1,domain:DEP 2,domain:DH,domain:PDZ,domain:PH,modified residue,sequence conflict,sequence variant,splice variant,
UROK_HUMAN	plasminogen activator, urokinase(PLAU)	Homo sapiens		h_fibrinolysisPathway:Fibrinolysis Pathway,h_plateletAppPathway:Platelet Amyloid Precursor Protein Pathway,		GO:0001666~response to hypoxia,GO:0006508~proteolysis,GO:0006935~chemotaxis,GO:0007165~signal transduction,GO:0007596~blood coagulation,GO:0010469~regulation of receptor activity,GO:0014909~smooth muscle cell migration,GO:0014910~regulation of smooth muscle cell migration,GO:0030335~positive regulation of cell migration,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0042127~regulation of cell proliferation,GO:0042730~fibrinolysis,GO:0061041~regulation of wound healing,GO:2000097~regulation of smooth muscle cell-matrix adhesion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0016301~kinase activity,	IPR000001:Kringle,IPR000742:Epidermal growth factor-like domain,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR013032:EGF-like, conserved site,IPR013806:Kringle-like fold,IPR018056:Kringle, conserved site,IPR018114:Peptidase S1, trypsin family, active site,	hsa04064:NF-kappa B signaling pathway,hsa04610:Complement and coagulation cascades,hsa05202:Transcriptional misregulation in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,	104300~Alzheimer disease, late-onset, susceptibility to,601709~Quebec platelet disorder,		SM00020:Tryp_SPc,SM00130:KR,	3D-structure,Alternative splicing,Blood coagulation,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Fibrinolysis,Glycoprotein,Hemostasis,Hydrolase,Kinase,Kringle,Pharmaceutical,Phosphoprotein,Plasminogen activation,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Serine protease,Signal,Transferase,Zymogen,	active site:Charge relay system,chain:Urokinase-type plasminogen activator,chain:Urokinase-type plasminogen activator chain B,chain:Urokinase-type plasminogen activator long chain A,chain:Urokinase-type plasminogen activator short chain A,disulfide bond,domain:EGF-like,domain:Kringle,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Fuc),helix,modified residue,mutagenesis site,region of interest:Binds urokinase plasminogen activator surface receptor,region of interest:Connecting peptide,sequence conflict,sequence variant,signal peptide,site:Cleavage; during zymogen activation,splice variant,strand,turn,
PHLA2_HUMAN	pleckstrin homology like domain family A member 2(PHLDA2)	Homo sapiens				GO:0001890~placenta development,GO:0006915~apoptotic process,GO:0009887~organ morphogenesis,GO:0010468~regulation of gene expression,GO:0030334~regulation of cell migration,GO:0045995~regulation of embryonic development,GO:0070873~regulation of glycogen metabolic process,	GO:0005737~cytoplasm,GO:0016020~membrane,		IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Reference proteome,	chain:Pleckstrin homology-like domain family A member 2,compositionally biased region:Poly-Ala,domain:PH,modified residue,sequence conflict,
PTGES_HUMAN	prostaglandin E synthase(PTGES)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,		GO:0001516~prostaglandin biosynthetic process,GO:0002526~acute inflammatory response,GO:0002544~chronic inflammatory response,GO:0006693~prostaglandin metabolic process,GO:0007165~signal transduction,GO:0008285~negative regulation of cell proliferation,GO:0014070~response to organic cyclic compound,GO:0019371~cyclooxygenase pathway,GO:0032496~response to lipopolysaccharide,GO:0032526~response to retinoic acid,GO:0034097~response to cytokine,GO:0051592~response to calcium ion,	GO:0005641~nuclear envelope lumen,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0043295~glutathione binding,GO:0050220~prostaglandin-E synthase activity,	IPR001129:Membrane-associated, eicosanoid/glutathione metabolism (MAPEG) protein,IPR023352:Membrane associated eicosanoid/glutathione metabolism-like domain,	hsa00590:Arachidonic acid metabolism,hsa01100:Metabolic pathways,				3D-structure,Complete proteome,Fatty acid biosynthesis,Fatty acid metabolism,Isomerase,Lipid biosynthesis,Lipid metabolism,Membrane,Prostaglandin biosynthesis,Prostaglandin metabolism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Prostaglandin E synthase,sequence conflict,transmembrane region,
PGH2_HUMAN	prostaglandin-endoperoxide synthase 2(PTGS2)	Homo sapiens		h_acetaminophenPathway:Mechanism of Acetaminophen Activity and Toxicity,h_eicosanoidPathway:Eicosanoid Metabolism,		GO:0001516~prostaglandin biosynthetic process,GO:0001525~angiogenesis,GO:0006693~prostaglandin metabolic process,GO:0006769~nicotinamide metabolic process,GO:0006928~movement of cell or subcellular component,GO:0006954~inflammatory response,GO:0006979~response to oxidative stress,GO:0007566~embryo implantation,GO:0007612~learning,GO:0007613~memory,GO:0008217~regulation of blood pressure,GO:0008285~negative regulation of cell proliferation,GO:0009750~response to fructose,GO:0010042~response to manganese ion,GO:0010226~response to lithium ion,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0019233~sensory perception of pain,GO:0019371~cyclooxygenase pathway,GO:0019372~lipoxygenase pathway,GO:0030282~bone mineralization,GO:0030728~ovulation,GO:0031394~positive regulation of prostaglandin biosynthetic process,GO:0031622~positive regulation of fever generation,GO:0031915~positive regulation of synaptic plasticity,GO:0032227~negative regulation of synaptic transmission, dopaminergic,GO:0032355~response to estradiol,GO:0032496~response to lipopolysaccharide,GO:0033280~response to vitamin D,GO:0034612~response to tumor necrosis factor,GO:0034644~cellular response to UV,GO:0035633~maintenance of blood-brain barrier,GO:0042346~positive regulation of NF-kappaB import into nucleus,GO:0042493~response to drug,GO:0042633~hair cycle,GO:0043065~positive regulation of apoptotic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045786~negative regulation of cell cycle,GO:0045907~positive regulation of vasoconstriction,GO:0045986~negative regulation of smooth muscle contraction,GO:0045987~positive regulation of smooth muscle contraction,GO:0046697~decidualization,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050727~regulation of inflammatory response,GO:0050873~brown fat cell differentiation,GO:0051384~response to glucocorticoid,GO:0051926~negative regulation of calcium ion transport,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0055114~oxidation-reduction process,GO:0070542~response to fatty acid,GO:0071260~cellular response to mechanical stimulus,GO:0071318~cellular response to ATP,GO:0071456~cellular response to hypoxia,GO:0071498~cellular response to fluid shear stress,GO:0071636~positive regulation of transforming growth factor beta production,GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis,GO:0090271~positive regulation of fibroblast growth factor production,GO:0090336~positive regulation of brown fat cell differentiation,GO:0090362~positive regulation of platelet-derived growth factor production,GO:0098869~cellular oxidant detoxification,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0005901~caveola,GO:0031090~organelle membrane,GO:0043005~neuron projection,GO:0043234~protein complex,	GO:0004601~peroxidase activity,GO:0004666~prostaglandin-endoperoxide synthase activity,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0019899~enzyme binding,GO:0020037~heme binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0050473~arachidonate 15-lipoxygenase activity,	IPR000742:Epidermal growth factor-like domain,IPR010255:Haem peroxidase,IPR019791:Haem peroxidase, animal, subgroup,	hsa00590:Arachidonic acid metabolism,hsa01100:Metabolic pathways,hsa04064:NF-kappa B signaling pathway,hsa04370:VEGF signaling pathway,hsa04668:TNF signaling pathway,hsa04723:Retrograde endocannabinoid signaling,hsa04726:Serotonergic synapse,hsa04913:Ovarian steroidogenesis,hsa04921:Oxytocin signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa05140:Leishmaniasis,hsa05200:Pathways in cancer,hsa05204:Chemical carcinogenesis,hsa05206:MicroRNAs in cancer,hsa05222:Small cell lung cancer,				3D-structure,Complete proteome,Dioxygenase,Disulfide bond,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Glycoprotein,Heme,Iron,Lipid biosynthesis,Lipid metabolism,Membrane,Metal-binding,Microsome,Oxidoreductase,Peroxidase,Polymorphism,Prostaglandin biosynthesis,Prostaglandin metabolism,Reference proteome,S-nitrosylation,Signal,	active site:For cyclooxygenase activity,active site:Proton acceptor,chain:Prostaglandin G/H synthase 2,disulfide bond,domain:EGF-like,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Iron (heme axial ligand),modified residue,sequence conflict,sequence variant,signal peptide,site:Aspirin-acetylated serine,
RAC2_HUMAN	ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)(RAC2)	Homo sapiens				GO:0006935~chemotaxis,GO:0007015~actin filament organization,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0008284~positive regulation of cell proliferation,GO:0010310~regulation of hydrogen peroxide metabolic process,GO:0010592~positive regulation of lamellipodium assembly,GO:0010810~regulation of cell-substrate adhesion,GO:0030031~cell projection assembly,GO:0030036~actin cytoskeleton organization,GO:0030168~platelet activation,GO:0042129~regulation of T cell proliferation,GO:0043304~regulation of mast cell degranulation,GO:0045453~bone resorption,GO:0045859~regulation of protein kinase activity,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0060263~regulation of respiratory burst,GO:0060753~regulation of mast cell chemotaxis,GO:0071593~lymphocyte aggregation,GO:0090023~positive regulation of neutrophil chemotaxis,GO:1902622~regulation of neutrophil migration,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005622~intracellular,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030027~lamellipodium,GO:0030670~phagocytic vesicle membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0019887~protein kinase regulator activity,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04310:Wnt signaling pathway,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04650:Natural killer cell mediated cytotoxicity,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05231:Choline metabolism in cancer,hsa05416:Viral myocarditis,	608203~Neutrophil immunodeficiency syndrome,			3D-structure,Acetylation,ADP-ribosylation,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Glycoprotein,GTP-binding,Lipoprotein,Methylation,Nucleotide-binding,Polymorphism,Prenylation,Proteomics identification,Reference proteome,Signal,	chain:Ras-related C3 botulinum toxin substrate 2,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,sequence variant,short sequence motif:Effector region,strand,turn,
RGS5_HUMAN	regulator of G-protein signaling 5(RGS5)	Homo sapiens				GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0009968~negative regulation of signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0005096~GTPase activator activity,	IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,		145500~Blood pressure regulation QTL,		SM00315:RGS,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Membrane,Reference proteome,Signal transduction inhibitor,	chain:Regulator of G-protein signaling 5,domain:RGS,helix,
SEM7A_HUMAN	semaphorin 7A (John Milton Hagen blood group)(SEMA7A)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0001755~neural crest cell migration,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007229~integrin-mediated signaling pathway,GO:0021988~olfactory lobe development,GO:0030335~positive regulation of cell migration,GO:0045773~positive regulation of axon extension,GO:0048675~axon extension,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050727~regulation of inflammatory response,GO:0050919~negative chemotaxis,GO:0060907~positive regulation of macrophage cytokine production,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071526~semaphorin-plexin signaling pathway,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0031225~anchored component of membrane,	GO:0005178~integrin binding,GO:0005515~protein binding,GO:0030215~semaphorin receptor binding,GO:0038191~neuropilin binding,GO:0045499~chemorepellent activity,	IPR001627:Semaphorin/CD100 antigen,IPR002165:Plexin,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016201:Plexin-like fold,IPR027231:Semaphorin,	hsa04360:Axon guidance,	614745~Blood group, John-Milton-Hagen system,		SM00423:PSI,SM00630:Sema,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Inflammatory response,Lipoprotein,Membrane,Methylation,Neurogenesis,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:Semaphorin-7A,disulfide bond,domain:Ig-like C2-type,domain:Sema,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated alanine,propeptide:Removed in mature form,sequence variant,short sequence motif:Cell attachment site,signal peptide,
PAI2_HUMAN	serpin family B member 2(SERPINB2)	Homo sapiens		h_fibrinolysisPathway:Fibrinolysis Pathway,		GO:0010951~negative regulation of endopeptidase activity,GO:0042060~wound healing,GO:0042730~fibrinolysis,GO:0043066~negative regulation of apoptotic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR000215:Serpin family,IPR015556:Protease inhibitor I4, serpin, plasminogen activator inhibitor-2,IPR023795:Protease inhibitor I4, serpin, conserved site,IPR023796:Serpin domain,	hsa05146:Amoebiasis,			SM00093:SERPIN,	3D-structure,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Glycoprotein,Plasminogen activation,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Secreted,Serine protease inhibitor,Signal,	chain:Plasminogen activator inhibitor 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,site:Reactive bond,strand,turn,
GDN_HUMAN	serpin family E member 2(SERPINE2)	Homo sapiens				GO:0007596~blood coagulation,GO:0008285~negative regulation of cell proliferation,GO:0010757~negative regulation of plasminogen activation,GO:0010766~negative regulation of sodium ion transport,GO:0010951~negative regulation of endopeptidase activity,GO:0010955~negative regulation of protein processing,GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling,GO:0021683~cerebellar granular layer morphogenesis,GO:0030195~negative regulation of blood coagulation,GO:0030308~negative regulation of cell growth,GO:0030334~regulation of cell migration,GO:0032940~secretion by cell,GO:0033363~secretory granule organization,GO:0042177~negative regulation of protein catabolic process,GO:0042628~mating plug formation,GO:0045861~negative regulation of proteolysis,GO:0045879~negative regulation of smoothened signaling pathway,GO:0048505~regulation of timing of cell differentiation,GO:0048711~positive regulation of astrocyte differentiation,GO:0050974~detection of mechanical stimulus involved in sensory perception,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0060291~long-term synaptic potentiation,GO:0060384~innervation,GO:0061108~seminal vesicle epithelium development,GO:0090331~negative regulation of platelet aggregation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005829~cytosol,GO:0031012~extracellular matrix,GO:0031091~platelet alpha granule,GO:0031232~extrinsic component of external side of plasma membrane,GO:0031594~neuromuscular junction,GO:1903561~extracellular vesicle,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,	IPR000215:Serpin family,IPR023795:Protease inhibitor I4, serpin, conserved site,IPR023796:Serpin domain,				SM00093:SERPIN,	3D-structure,Alternative splicing,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Glycoprotein,Heparin-binding,Neurogenesis,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Secreted,Serine protease inhibitor,Signal,	chain:Glia-derived nexin,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,site:Reactive bond,splice variant,
UT1_HUMAN	solute carrier family 14 member 1 (Kidd blood group)(SLC14A1)	Homo sapiens				GO:0006833~water transport,GO:0015840~urea transport,GO:0055085~transmembrane transport,GO:0071918~urea transmembrane transport,	GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005372~water transmembrane transporter activity,GO:0015204~urea transmembrane transporter activity,GO:0015265~urea channel activity,	IPR004937:Urea transporter,		111000~Blood group, Kidd,	PIRSF016502:urea transporter,		Alternative splicing,Blood group antigen,Cell membrane,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Urea transporter 1,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,transmembrane region,
MOT7_HUMAN	solute carrier family 16 member 6(SLC16A6)	Homo sapiens				GO:0015718~monocarboxylic acid transport,GO:0035879~plasma membrane lactate transport,GO:0055085~transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008028~monocarboxylic acid transmembrane transporter activity,GO:0015129~lactate transmembrane transporter activity,GO:0015293~symporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Cell membrane,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Monocarboxylate transporter 7,modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
S20A1_HUMAN	solute carrier family 20 member 1(SLC20A1)	Homo sapiens				GO:0006796~phosphate-containing compound metabolic process,GO:0006810~transport,GO:0006811~ion transport,GO:0006817~phosphate ion transport,GO:0007165~signal transduction,GO:0035435~phosphate ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0044341~sodium-dependent phosphate transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0005315~inorganic phosphate transmembrane transporter activity,GO:0005316~high-affinity inorganic phosphate:sodium symporter activity,GO:0005436~sodium:phosphate symporter activity,GO:0015319~sodium:inorganic phosphate symporter activity,GO:0015321~sodium-dependent phosphate transmembrane transporter activity,	IPR001204:Phosphate transporter,					Complete proteome,Membrane,Phosphate transport,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium-dependent phosphate transporter 1,modified residue,mutagenesis site,region of interest:A,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
S23A2_HUMAN	solute carrier family 23 member 2(SLC23A2)	Homo sapiens		h_vitCBPathway:Vitamin C in the Brain,		GO:0006139~nucleobase-containing compound metabolic process,GO:0006979~response to oxidative stress,GO:0015851~nucleobase transport,GO:0015882~L-ascorbic acid transport,GO:0015993~molecular hydrogen transport,GO:0019852~L-ascorbic acid metabolic process,GO:0035461~vitamin transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0070904~transepithelial L-ascorbic acid transport,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009925~basal plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,	GO:0008520~L-ascorbate:sodium symporter activity,GO:0008523~sodium-dependent multivitamin transmembrane transporter activity,GO:0015205~nucleobase transmembrane transporter activity,GO:0015229~L-ascorbic acid transporter activity,GO:0070890~sodium-dependent L-ascorbate transmembrane transporter activity,	IPR006042:Xanthine/uracil permease,IPR006043:Xanthine/uracil/vitamin C permease,					Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 23 member 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,transmembrane region,
S6A15_HUMAN	solute carrier family 6 member 15(SLC6A15)	Homo sapiens				GO:0006814~sodium ion transport,GO:0006836~neurotransmitter transport,GO:0006865~amino acid transport,GO:0015804~neutral amino acid transport,GO:0015820~leucine transport,GO:0015824~proline transport,GO:0035524~proline transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005298~proline:sodium symporter activity,GO:0005326~neurotransmitter transporter activity,GO:0005328~neurotransmitter:sodium symporter activity,GO:0015171~amino acid transmembrane transporter activity,	IPR000175:Sodium:neurotransmitter symporter,IPR002438:Sodium:neurotransmitter symporter, orphan,					Alternative splicing,Amino-acid transport,Complete proteome,Glycoprotein,Ion transport,Membrane,Neurotransmitter transport,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Orphan sodium- and chloride-dependent neurotransmitter transporter NTT73,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
E9PHV5_HUMAN	sperm specific antigen 2(SSFA2)	Homo sapiens					GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0005102~receptor binding,GO:0051015~actin filament binding,	IPR026648:Sperm-specific antigen 2,				SM01257:SM01257,	Actin-binding,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Isopeptide bond,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Sperm-specific antigen 2,modified residue,sequence conflict,sequence variant,splice variant,
STC1_HUMAN	stanniocalcin 1(STC1)	Homo sapiens				GO:0001503~ossification,GO:0001886~endothelial cell morphogenesis,GO:0003421~growth plate cartilage axis specification,GO:0006874~cellular calcium ion homeostasis,GO:0007566~embryo implantation,GO:0010596~negative regulation of endothelial cell migration,GO:0030336~negative regulation of cell migration,GO:0033280~response to vitamin D,GO:0035988~chondrocyte proliferation,GO:0044070~regulation of anion transport,GO:0046697~decidualization,GO:0051926~negative regulation of calcium ion transport,GO:0060348~bone development,GO:0071320~cellular response to cAMP,GO:0071385~cellular response to glucocorticoid stimulus,GO:0071456~cellular response to hypoxia,GO:0086004~regulation of cardiac muscle cell contraction,GO:0090280~positive regulation of calcium ion import,GO:1903403~negative regulation of renal phosphate excretion,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016324~apical plasma membrane,	GO:0005179~hormone activity,	IPR004978:Stanniocalcin,					Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hormone,Reference proteome,Secreted,Signal,	chain:Stanniocalcin-1,disulfide bond,glycosylation site:N-linked (GlcNAc...),signal peptide,
SYUA_HUMAN	synuclein alpha(SNCA)	Homo sapiens		h_parkinPathway:Role of Parkin in the Ubiquitin-Proteasomal Pathway,h_parkinsonsPathway:Alpha-synuclein and Parkin-mediated proteolysis in Parkinson's disease,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001774~microglial cell activation,GO:0001921~positive regulation of receptor recycling,GO:0001933~negative regulation of protein phosphorylation,GO:0001956~positive regulation of neurotransmitter secretion,GO:0006631~fatty acid metabolic process,GO:0006638~neutral lipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007006~mitochondrial membrane organization,GO:0007568~aging,GO:0008344~adult locomotory behavior,GO:0010040~response to iron(II) ion,GO:0010517~regulation of phospholipase activity,GO:0010642~negative regulation of platelet-derived growth factor receptor signaling pathway,GO:0014048~regulation of glutamate secretion,GO:0014059~regulation of dopamine secretion,GO:0031115~negative regulation of microtubule polymerization,GO:0031623~receptor internalization,GO:0031648~protein destabilization,GO:0032026~response to magnesium ion,GO:0032410~negative regulation of transporter activity,GO:0032496~response to lipopolysaccharide,GO:0032769~negative regulation of monooxygenase activity,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034341~response to interferon-gamma,GO:0034599~cellular response to oxidative stress,GO:0035067~negative regulation of histone acetylation,GO:0040012~regulation of locomotion,GO:0042416~dopamine biosynthetic process,GO:0042493~response to drug,GO:0042775~mitochondrial ATP synthesis coupled electron transport,GO:0043030~regulation of macrophage activation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043206~extracellular fibril organization,GO:0043524~negative regulation of neuron apoptotic process,GO:0044267~cellular protein metabolic process,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045807~positive regulation of endocytosis,GO:0045920~negative regulation of exocytosis,GO:0045963~negative regulation of dopamine metabolic process,GO:0048148~behavioral response to cocaine,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048488~synaptic vesicle endocytosis,GO:0050808~synapse organization,GO:0050812~regulation of acyl-CoA biosynthetic process,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051583~dopamine uptake involved in synaptic transmission,GO:0051585~negative regulation of dopamine uptake involved in synaptic transmission,GO:0051612~negative regulation of serotonin uptake,GO:0051622~negative regulation of norepinephrine uptake,GO:0055074~calcium ion homeostasis,GO:0055114~oxidation-reduction process,GO:0060079~excitatory postsynaptic potential,GO:0060291~long-term synaptic potentiation,GO:0060732~positive regulation of inositol phosphate biosynthetic process,GO:0070495~negative regulation of thrombin receptor signaling pathway,GO:0070555~response to interleukin-1,GO:0071280~cellular response to copper ion,GO:0071872~cellular response to epinephrine stimulus,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:1901215~negative regulation of neuron death,GO:1902957~negative regulation of mitochondrial electron transport, NADH to ubiquinone,GO:1903284~positive regulation of glutathione peroxidase activity,GO:1903285~positive regulation of hydrogen peroxide catabolic process,GO:1903421~regulation of synaptic vesicle recycling,GO:1903426~regulation of reactive oxygen species biosynthetic process,GO:1904715~negative regulation of chaperone-mediated autophagy,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005640~nuclear outer membrane,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005747~mitochondrial respiratory chain complex I,GO:0005764~lysosome,GO:0005791~rough endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0008021~synaptic vesicle,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016234~inclusion body,GO:0030054~cell junction,GO:0030424~axon,GO:0030426~growth cone,GO:0030659~cytoplasmic vesicle membrane,GO:0031092~platelet alpha granule membrane,GO:0043195~terminal bouton,GO:0043205~fibril,GO:0048471~perinuclear region of cytoplasm,GO:0098794~postsynapse,	GO:0000287~magnesium ion binding,GO:0005504~fatty acid binding,GO:0005507~copper ion binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008017~microtubule binding,GO:0008198~ferrous iron binding,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0019894~kinesin binding,GO:0019904~protein domain specific binding,GO:0030544~Hsp70 protein binding,GO:0042393~histone binding,GO:0042802~identical protein binding,GO:0043014~alpha-tubulin binding,GO:0043027~cysteine-type endopeptidase inhibitor activity involved in apoptotic process,GO:0043274~phospholipase binding,GO:0044212~transcription regulatory region DNA binding,GO:0045502~dynein binding,GO:0047485~protein N-terminus binding,GO:0048156~tau protein binding,GO:0048487~beta-tubulin binding,GO:0051219~phosphoprotein binding,GO:0060961~phospholipase D inhibitor activity,	IPR001058:Synuclein,IPR002460:Alpha-synuclein,	hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,	127750~Dementia, Lewy body,168601~Parkinson disease 1,605543~Parkinson disease 4,			3D-structure,Acetylation,Alternative splicing,Alzheimer disease,Amyloid,Cell junction,Complete proteome,Copper,Cytoplasm,Direct protein sequencing,Disease mutation,Membrane,Metal-binding,Neurodegeneration,Nucleus,Parkinson disease,Parkinsonism,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Secreted,Synapse,Ubl conjugation,	chain:Alpha-synuclein,helix,modified residue,mutagenesis site,region of interest:4 X 11 AA tandem repeats of [EGS]-K-T-K- [EQ]-[GQ]-V-X(4),repeat:1,repeat:2,repeat:3; approximate,repeat:4,sequence variant,splice variant,strand,turn,
SYUG_HUMAN	synuclein gamma(SNCG)	Homo sapiens				GO:0007268~chemical synaptic transmission,GO:0008344~adult locomotory behavior,GO:0009306~protein secretion,GO:0014059~regulation of dopamine secretion,GO:0046928~regulation of neurotransmitter secretion,GO:0050808~synapse organization,	GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0030424~axon,GO:0043025~neuronal cell body,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR001058:Synuclein,IPR002462:Gamma-synuclein,					Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Gamma-synuclein,modified residue,region of interest:4 X 11 AA tandem repeats of [EGSA]-K-T-K- [EQ]-[GQ]-V-X(4),repeat:1,repeat:2,repeat:3; approximate,repeat:4,sequence conflict,sequence variant,
TENA_HUMAN	tenascin C(TNC)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0007155~cell adhesion,GO:0007162~negative regulation of cell adhesion,GO:0007528~neuromuscular junction development,GO:0008284~positive regulation of cell proliferation,GO:0009611~response to wounding,GO:0009612~response to mechanical stimulus,GO:0010628~positive regulation of gene expression,GO:0014012~peripheral nervous system axon regeneration,GO:0030198~extracellular matrix organization,GO:0042060~wound healing,GO:0042127~regulation of cell proliferation,GO:0042475~odontogenesis of dentin-containing tooth,GO:0045471~response to ethanol,GO:0060447~bud outgrowth involved in lung branching,GO:0060739~mesenchymal-epithelial cell signaling involved in prostate gland development,GO:0060740~prostate gland epithelium morphogenesis,GO:0071300~cellular response to retinoic acid,GO:0071305~cellular response to vitamin D,GO:0071774~response to fibroblast growth factor,GO:0071799~cellular response to prostaglandin D stimulus,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005614~interstitial matrix,GO:0005615~extracellular space,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0045545~syndecan binding,	IPR000742:Epidermal growth factor-like domain,IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR003961:Fibronectin, type III,IPR013032:EGF-like, conserved site,IPR013111:EGF, extracellular,IPR013783:Immunoglobulin-like fold,IPR014715:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05206:MicroRNAs in cancer,	615629~Deafness, autosomal dominant 56,		SM00060:FN3,SM00181:EGF,SM00186:FBG,	3D-structure,Alternative splicing,Cell adhesion,Coiled coil,Complete proteome,Deafness,Direct protein sequencing,Disease mutation,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Non-syndromic deafness,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Tenascin,disulfide bond,domain:EGF-like 10,domain:EGF-like 11,domain:EGF-like 12,domain:EGF-like 13,domain:EGF-like 14,domain:EGF-like 15,domain:EGF-like 1; incomplete,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8,domain:EGF-like 9,domain:Fibrinogen C-terminal,domain:Fibronectin type-III 1,domain:Fibronectin type-III 10,domain:Fibronectin type-III 11,domain:Fibronectin type-III 12,domain:Fibronectin type-III 13,domain:Fibronectin type-III 14,domain:Fibronectin type-III 15,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Fibronectin type-III 9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,strand,
THAS_HUMAN	thromboxane A synthase 1(TBXAS1)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,	Secondary metabolites biosynthesis, transport, and catabolism,	GO:0006690~icosanoid metabolic process,GO:0019371~cyclooxygenase pathway,GO:0030644~cellular chloride ion homeostasis,GO:0045471~response to ethanol,GO:0045907~positive regulation of vasoconstriction,GO:0055114~oxidation-reduction process,GO:0070542~response to fatty acid,	GO:0005623~cell,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0004497~monooxygenase activity,GO:0004796~thromboxane-A synthase activity,GO:0005506~iron ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0020037~heme binding,GO:0036134~12-hydroxyheptadecatrienoic acid synthase activity,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR017972:Cytochrome P450, conserved site,	hsa00590:Arachidonic acid metabolism,hsa01100:Metabolic pathways,hsa04611:Platelet activation,	231095~Ghosal hematodiaphyseal syndrome,614158~Thromboxane synthase deficiency,			Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Heme,Iron,Isomerase,Lipid biosynthesis,Lipid metabolism,Membrane,Metal-binding,Monooxygenase,Oxidoreductase,Polymorphism,Prostaglandin biosynthesis,Prostaglandin metabolism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Thromboxane-A synthase,metal ion-binding site:Iron (heme axial ligand),sequence conflict,sequence variant,transmembrane region,
TFPI2_HUMAN	tissue factor pathway inhibitor 2(TFPI2)	Homo sapiens				GO:0007596~blood coagulation,GO:0010951~negative regulation of endopeptidase activity,GO:0071498~cellular response to fluid shear stress,	GO:0005578~proteinaceous extracellular matrix,GO:0005634~nucleus,GO:0031012~extracellular matrix,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005201~extracellular matrix structural constituent,	IPR002223:Proteinase inhibitor I2, Kunitz metazoa,IPR020901:Proteinase inhibitor I2, Kunitz, conserved site,				SM00131:KU,	3D-structure,Alternative splicing,Blood coagulation,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hemostasis,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease inhibitor,Signal,	chain:Tissue factor pathway inhibitor 2,compositionally biased region:Poly-Lys,disulfide bond,domain:BPTI/Kunitz inhibitor 1,domain:BPTI/Kunitz inhibitor 2,domain:BPTI/Kunitz inhibitor 3,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,site:Reactive bond,strand,turn,
BGH3_HUMAN	transforming growth factor beta induced(TGFBI)	Homo sapiens				GO:0001525~angiogenesis,GO:0002062~chondrocyte differentiation,GO:0007155~cell adhesion,GO:0007162~negative regulation of cell adhesion,GO:0007601~visual perception,GO:0008283~cell proliferation,GO:0030198~extracellular matrix organization,GO:0044267~cellular protein metabolic process,GO:0050896~response to stimulus,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0050840~extracellular matrix binding,	IPR000782:FAS1 domain,IPR011489:EMI domain,IPR016666:TGF beta-induced protein bIGH3/osteoblast-specific factor 2,		121820~Corneal dystrophy, epithelial basement membrane,121900~Corneal dystrophy, Groenouw type I,122200~Corneal dystrophy, lattice type I,602082~Corneal dystrophy, Thiel-Behnke type,607541~Corneal dystrophy, Avellino type,608470~Corneal dystrophy, Reis-Bucklers type,608471~Corneal dystrophy, lattice type IIIA,	PIRSF016553:TGF beta-induced protein bIGH3/osteoblast-specific factor 2,	SM00554:FAS1,	3D-structure,Amyloid,Amyloidosis,Cell adhesion,Complete proteome,Corneal dystrophy,Direct protein sequencing,Disease mutation,Disulfide bond,Extracellular matrix,Gamma-carboxyglutamic acid,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Sensory transduction,Signal,Vision,	chain:Transforming growth factor-beta-induced protein ig-h3,disulfide bond,domain:EMI,domain:FAS1 1,domain:FAS1 2,domain:FAS1 3,domain:FAS1 4,helix,modified residue,sequence variant,short sequence motif:Cell attachment site,signal peptide,strand,turn,
TAGL3_HUMAN	transgelin 3(TAGLN3)	Homo sapiens			Cytoskeleton,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0007417~central nervous system development,	GO:0005634~nucleus,GO:0043209~myelin sheath,		IPR000557:Calponin repeat,IPR001715:Calponin homology domain,IPR003096:Smooth muscle protein/calponin,				SM00033:CH,	Complete proteome,Direct protein sequencing,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Transgelin-3,domain:CH,modified residue,repeat:Calponin-like,
T132A_HUMAN	transmembrane protein 132A(TMEM132A)	Homo sapiens					GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,		IPR026307:Transmembrane protein 132,					Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 132A,compositionally biased region:Glu-rich,glycosylation site:N-linked (GlcNAc...),region of interest:Binds to HSPA5/GRP78,region of interest:Confers cellular localization similar to full-length form,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
UPP1_HUMAN	uridine phosphorylase 1(UPP1)	Homo sapiens				GO:0006139~nucleobase-containing compound metabolic process,GO:0006218~uridine catabolic process,GO:0009116~nucleoside metabolic process,GO:0009166~nucleotide catabolic process,GO:0042149~cellular response to glucose starvation,GO:0043097~pyrimidine nucleoside salvage,GO:0044206~UMP salvage,GO:0046135~pyrimidine nucleoside catabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0004850~uridine phosphorylase activity,GO:0016763~transferase activity, transferring pentosyl groups,	IPR000845:Nucleoside phosphorylase domain,IPR010059:Uridine phosphorylase, eukaryotic,IPR018016:Nucleoside phosphorylase, conserved site,IPR018017:Nucleoside phosphorylase,	hsa00240:Pyrimidine metabolism,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,				3D-structure,Alternative splicing,Complete proteome,Glycosyltransferase,Proteomics identification,Reference proteome,Transferase,	chain:Uridine phosphorylase 1,helix,splice variant,strand,turn,
CSPG2_HUMAN	versican(VCAN)	Homo sapiens				GO:0001501~skeletal system development,GO:0001649~osteoblast differentiation,GO:0007155~cell adhesion,GO:0007275~multicellular organism development,GO:0007417~central nervous system development,GO:0008037~cell recognition,GO:0008347~glial cell migration,GO:0030198~extracellular matrix organization,GO:0030203~glycosaminoglycan metabolic process,GO:0030206~chondroitin sulfate biosynthetic process,GO:0030207~chondroitin sulfate catabolic process,GO:0030208~dermatan sulfate biosynthetic process,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005796~Golgi lumen,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0043202~lysosomal lumen,GO:0043231~intracellular membrane-bounded organelle,	GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005539~glycosaminoglycan binding,GO:0005540~hyaluronic acid binding,GO:0030246~carbohydrate binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000436:Sushi/SCR/CCP,IPR000538:Link,IPR000742:Epidermal growth factor-like domain,IPR001304:C-type lectin,IPR001881:EGF-like calcium-binding,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013032:EGF-like, conserved site,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018097:EGF-like calcium-binding, conserved site,IPR018378:C-type lectin, conserved site,	hsa04514:Cell adhesion molecules (CAMs),	143200~Wagner syndrome 1,		SM00032:CCP,SM00034:CLECT,SM00179:EGF_CA,SM00181:EGF,SM00409:IG,SM00445:LINK,	Alternative splicing,Calcium,Cataract,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Hyaluronic acid,Immunoglobulin domain,Lectin,Phosphoprotein,Polymorphism,Proteoglycan,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Versican core protein,disulfide bond,domain:C-type lectin,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:Ig-like V-type,domain:Link 1,domain:Link 2,domain:Sushi,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:GAG-alpha (glucosaminoglycan attachment domain),region of interest:GAG-beta,sequence conflict,sequence variant,signal peptide,splice variant,
VMA5A_HUMAN	von Willebrand factor A domain containing 5A(VWA5A)	Homo sapiens					GO:0005634~nucleus,GO:0005654~nucleoplasm,		IPR002035:von Willebrand factor, type A,IPR013694:VIT domain,				SM00327:VWA,SM00609:VIT,	Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:von Willebrand factor A domain-containing protein 5A,domain:VIT,domain:VWFA,sequence variant,splice variant,
WLS_HUMAN	wntless Wnt ligand secretion mediator(WLS)	Homo sapiens				GO:0001707~mesoderm formation,GO:0006886~intracellular protein transport,GO:0009948~anterior/posterior axis specification,GO:0016055~Wnt signaling pathway,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030901~midbrain development,GO:0030902~hindbrain development,GO:0031017~exocrine pancreas development,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0061355~Wnt protein secretion,GO:0061357~positive regulation of Wnt protein secretion,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000139~Golgi membrane,GO:0005769~early endosome,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030666~endocytic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0031901~early endosome membrane,GO:0032590~dendrite membrane,GO:0032839~dendrite cytoplasm,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0017147~Wnt-protein binding,GO:0031852~mu-type opioid receptor binding,	IPR009551:Protein wntless,					Alternative splicing,Cell membrane,Complete proteome,Cytoplasmic vesicle,Developmental protein,Endoplasmic reticulum,Endosome,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Wnt signaling pathway,	chain:Integral membrane protein GPR177,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TUT7_HUMAN	zinc finger CCHC-type containing 6(ZCCHC6)	Homo sapiens			DNA replication, recombination, and repair,	GO:0031123~RNA 3'-end processing,GO:0071044~histone mRNA catabolic process,	GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0008270~zinc ion binding,GO:0016779~nucleotidyltransferase activity,GO:0044822~poly(A) RNA binding,GO:0050265~RNA uridylyltransferase activity,	IPR001878:Zinc finger, CCHC-type,IPR002058:PAP/25A-associated,IPR002934:Nucleotidyl transferase domain,IPR003604:Zinc finger, U1-type,				SM00343:ZnF_C2HC,SM00451:ZnF_U1,	Alternative splicing,Complete proteome,Cytoplasm,Magnesium,Manganese,Metal-binding,Nucleotidyltransferase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transferase,Zinc,Zinc-finger,	chain:Terminal uridylyltransferase 7,compositionally biased region:Glu-rich,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Asp,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:CCHC-type 1,zinc finger region:CCHC-type 2,zinc finger region:CCHC-type 3,
